Home › Funds › Equitable › EQ/Common Stock Index Portfolio
Fund family: Equitable · Filed by EQ ADVISORS TRUST (CIK 1027263) · SEC series S000010734
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 15,321 with, 417 against, 59 abstentions (not counted as with management); 10 items carried no recommendation. Shareholder proposals: 166 FOR, 251 AGAINST, 2 abstained, by the filing’s own vote-source field.
The same two figures as Equitable’s manager page (393,894 ballot items across 72 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Equitable | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 87.8% | 14,985 | 92.5% | 339,726 |
| Backed environmental and social shareholder proposals at US companies | 20.0% | 165 | 9.6% | 3,486 |
Each ballot item this fund voted is set against the votes of the other Equitable funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Equitable funds on 1,127 items (7.3% of the 15,400 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Equitable funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Rackspace Technology, Inc. | 2026-06-18 | Approve an amendment to the Company's 2020 Equity Incentive Plan to increase the number of shares of common stock authorized to be issued under the plan. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 92.2% support |
| Vaxcyte, Inc. | 2026-06-15 | 3 wordings Election of Class III Directors Nominees would serve until the 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Olivier Brandicourt, M.D. | Withhold | FOR — 7 of 8 Equitable funds | Against | Passed (calculated), 87.5% support |
| Oracle Corporation | 2025-11-18 | Election of Directors: Charles W. Moorman | Withhold | FOR — 17 of 24 Equitable funds | Against | Elected, 97.8% support |
| Oracle Corporation | 2025-11-18 | Election of Directors: George H. Conrades | Withhold | FOR — 17 of 24 Equitable funds | Against | Elected, 92.3% support |
| Oracle Corporation | 2025-11-18 | Election of Directors: Jeffrey S. Berg | Withhold | FOR — 17 of 24 Equitable funds | Against | Elected, 92.2% support |
| Oracle Corporation | 2025-11-18 | Election of Directors: Naomi O. Seligman | Withhold | FOR — 17 of 24 Equitable funds | Against | Elected, 92.6% support |
| Oracle Corporation | 2025-11-18 | Election of Directors: Rona A. Fairhead | Withhold | FOR — 17 of 24 Equitable funds | Against | Elected, 98.4% support |
| Meta Platforms, Inc. | 2026-05-27 | Election of Directors: Nancy Killefer | Withhold | FOR — 16 of 23 Equitable funds | Against | Elected, 97.3% support |
| Roblox Corporation | 2026-05-28 | Election of Class II Directors: David Baszucki | Withhold | FOR — 6 of 7 Equitable funds | Against | Elected, 93.9% support |
| Praxis Precision Medicines, Inc. | 2026-06-10 | To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Gregory Norden | Withhold | FOR — 8 of 10 Equitable funds | Against | Passed (calculated), 98.8% support |
| Praxis Precision Medicines, Inc. | 2026-06-10 | To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: William Young | Withhold | FOR — 8 of 10 Equitable funds | Against | Passed (calculated), 85.5% support |
| Cerence Inc. | 2026-02-12 | Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers, as disclosed in the proxy statement. | Against | FOR — 6 of 7 Equitable funds | Against | Passed (calculated), 77.2% support |
| ZimVie Inc. | 2025-10-10 | A proposal to adopt the Agreement and Plan of Merger, dated as of July 20, 2025 (the "merger agreement"), by and among ZimVie Inc. (the "Company"), Zamboni Parent Inc. ("Parent"), and Zamboni MergerCo Inc. ("MergerCo"), pursuant to which and subject to the terms and conditions thereof, MergerCo will | Abstain | FOR — 6 of 7 Equitable funds | Against | Approved, 99.9% support |
| ZimVie Inc. | 2025-10-10 | A proposal to approve any adjournment of the special meeting for the purpose of soliciting additional proxies if there are insufficient votes at the special meeting to approve Proposal 1. | Abstain | FOR — 6 of 7 Equitable funds | Against | — |
| Danaher Corporation | 2026-05-05 | To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: A. Shane Sanders | Against | FOR — 14 of 20 Equitable funds | Against | Elected, 73.8% support |
| Danaher Corporation | 2026-05-05 | To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Alan G. Spoon | Against | FOR — 14 of 20 Equitable funds | Against | Elected, 92.5% support |
| Danaher Corporation | 2026-05-05 | To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Charles W. Lamanna | Against | FOR — 14 of 20 Equitable funds | Against | Elected, 99.2% support |
| Danaher Corporation | 2026-05-05 | To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Elias A. Zerhouni, MD | Against | FOR — 14 of 20 Equitable funds | Against | Elected, 90.6% support |
| Danaher Corporation | 2026-05-05 | To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Feroz Dewan | Against | FOR — 14 of 20 Equitable funds | Against | Elected, 96.4% support |
| Danaher Corporation | 2026-05-05 | To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Linda Filler | Against | FOR — 14 of 20 Equitable funds | Against | Elected, 81.4% support |
| Danaher Corporation | 2026-05-05 | To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Mitchell P. Rales | Against | FOR — 14 of 20 Equitable funds | Against | Elected, 98.2% support |
| Danaher Corporation | 2026-05-05 | To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Rainer M. Blair | Against | FOR — 14 of 20 Equitable funds | Against | Elected, 98.8% support |
| Danaher Corporation | 2026-05-05 | To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Raymond C. Stevens, Ph.D. | Against | FOR — 14 of 20 Equitable funds | Against | Elected, 79.7% support |
| Danaher Corporation | 2026-05-05 | To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Steven M. Rales | Against | FOR — 14 of 20 Equitable funds | Against | Elected, 97.2% support |
| Danaher Corporation | 2026-05-05 | To elect the eleven directors named in the attached Proxy Statement to hold office until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified: Teri L. List | Against | FOR — 14 of 20 Equitable funds | Against | Elected, 77.7% support |
| Company | Meeting | Item | This fund | Most Equitable funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Oracle Corporation | 2025-11-18 | Election of Directors: Jeffrey O. Henley | Withhold | FOR — 16 of 24 Equitable funds | Against | Elected, 92.0% support |
| Oracle Corporation | 2025-11-18 | Election of Directors: Michael J. Boskin | Withhold | FOR — 16 of 24 Equitable funds | Against | Elected, 91.3% support |
| Wells Fargo & Company | 2026-04-28 | Shareholder Shareholder Proposal - Energy Supply Ratio. | For | AGAINST — 12 of 17 Equitable funds | Against | Failed (calculated), 20.6% support |
| Dominion Energy, Inc. | 2026-05-05 | Shareholder Shareholder Proposal Regarding a Policy for an Independent Chair | For | AGAINST — 12 of 17 Equitable funds | Against | Not approved, 24.5% support |
| Datadog, Inc. | 2026-06-15 | To elect four Class I directors, each to hold office until our Annual Meeting of Stockholders in 2029: Olivier Pomel | Withhold | FOR — 13 of 19 Equitable funds | Against | Passed (calculated), 98.1% support |
| NIKE, Inc. | 2025-09-09 | To approve executive compensation by an advisory vote. | Against | FOR — 13 of 19 Equitable funds | Against | Passed (calculated), 93.6% support |
| Targa Resources Corp. | 2026-05-21 | To elect the four Class I Directors named in the proxy statement, each to serve until the 2029 annual meeting of stockholders: Charles R. Crisp | Against | FOR — 13 of 19 Equitable funds | Against | Elected, 96.4% support |
| Targa Resources Corp. | 2026-05-21 | To elect the four Class I Directors named in the proxy statement, each to serve until the 2029 annual meeting of stockholders: Laura C. Fulton | Against | FOR — 13 of 19 Equitable funds | Against | Elected, 87.2% support |
| Targa Resources Corp. | 2026-05-21 | To elect the four Class I Directors named in the proxy statement, each to serve until the 2029 annual meeting of stockholders: Paul W. Chung | Against | FOR — 13 of 19 Equitable funds | Against | Elected, 94.0% support |
| Targa Resources Corp. | 2026-05-21 | To elect the four Class I Directors named in the proxy statement, each to serve until the 2029 annual meeting of stockholders: R. Keith Teague | Against | FOR — 13 of 19 Equitable funds | Against | Elected, 96.9% support |
| Meta Platforms, Inc. | 2026-05-27 | Election of Directors: Charles Songhurst | Withhold | FOR — 15 of 23 Equitable funds | Against | Elected, 99.1% support |
| Meta Platforms, Inc. | 2026-05-27 | Election of Directors: John Arnold | Withhold | FOR — 15 of 23 Equitable funds | Against | Elected, 99.0% support |
| Meta Platforms, Inc. | 2026-05-27 | Election of Directors: Patrick Collison | Withhold | FOR — 15 of 23 Equitable funds | Against | Elected, 99.0% support |
| Cogent Biosciences, Inc. | 2026-06-09 | Election of the three Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Arlene M. Morris | Withhold | FOR — 7 of 9 Equitable funds | Against | Elected, 83.9% support |
| Cogent Biosciences, Inc. | 2026-06-09 | Election of the three Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Dr. Chris Cain | Withhold | FOR — 7 of 9 Equitable funds | Against | Elected, 86.8% support |
| Cogent Biosciences, Inc. | 2026-06-09 | Election of the three Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Todd Shegog | Withhold | FOR — 7 of 9 Equitable funds | Against | Elected, 86.7% support |
| Johnson & Johnson | 2026-04-23 | Election of Directors: Mark A. Weinberger | Against | FOR — 12 of 18 Equitable funds | Against | Passed (calculated), 96.4% support |
| Capital One Financial Corporation | 2026-05-08 | Advisory vote on our Named Executive Officer compensation ("Say on Pay"). | Against | FOR — 11 of 16 Equitable funds | Against | Passed (calculated), 83.5% support |
| AMETEK, Inc. | 2026-05-07 | Election of Directors for a term of three years: Anthony J. Conti | Against | FOR — 12 of 18 Equitable funds | Against | Elected, 89.8% support |
| AMETEK, Inc. | 2026-05-07 | Election of Directors for a term of three years: Gretchen W. McClain | Against | FOR — 12 of 18 Equitable funds | Against | Elected, 86.7% support |
| AMETEK, Inc. | 2026-05-07 | Election of Directors for a term of three years: Thomas A. Amato | Against | FOR — 12 of 18 Equitable funds | Against | Elected, 93.8% support |
| The Estee Lauder Companies Inc. | 2025-11-13 | Election of five (5) Class II Directors: Richard F. Zannino | Withhold | FOR — 12 of 18 Equitable funds | Against | Passed (calculated), 99.0% support |
| Kodiak Sciences Inc. | 2026-06-02 | Elect three Class II directors nominated by our board and named in this proxy statement: Bassil I. Dahiyat, Ph.D. | Withhold | FOR — 5 of 6 Equitable funds | Against | Elected, 98.7% support |
| Kodiak Sciences Inc. | 2026-06-02 | Elect three Class II directors nominated by our board and named in this proxy statement: Charles A. Bancroft | Withhold | FOR — 5 of 6 Equitable funds | Against | Elected, 78.7% support |
| Kodiak Sciences Inc. | 2026-06-02 | Elect three Class II directors nominated by our board and named in this proxy statement: Taiyin Yang, Ph.D. | Withhold | FOR — 5 of 6 Equitable funds | Against | Elected, 99.4% support |
| CRISPR Therapeutics AG | 2026-06-04 | Binding vote on maximum non-performance-related compensation for members of the Executive Committee from July 1, 2026 to June 30, 2027. | Against | FOR — 5 of 6 Equitable funds | Against | — |
| CRISPR Therapeutics AG | 2026-06-04 | Binding vote on maximum variable compensation for members of the Executive Committee for the current year ending December 31, 2026. | Against | FOR — 5 of 6 Equitable funds | Against | — |
| CRISPR Therapeutics AG | 2026-06-04 | Re-election of Douglas A. Treco, Ph.D. | For | AGAINST — 5 of 6 Equitable funds | For | Elected, 91.1% support |
| Standex International Corporation | 2025-10-21 | To elect the following Directors: Class III - for a three-year term expiring in 2028: Thomas E. Chorman (Class III, 3 year term) | Against | FOR — 5 of 6 Equitable funds | Against | Passed (calculated), 88.5% support |
| Replimune Group, Inc. | 2025-09-03 | Election of Directors: Christy Oliger | Withhold | FOR — 5 of 6 Equitable funds | Against | Elected, 92.4% support |
| Replimune Group, Inc. | 2025-09-03 | Election of Directors: Joseph Slattery | Withhold | FOR — 5 of 6 Equitable funds | Against | Elected, 91.3% support |
| Replimune Group, Inc. | 2025-09-03 | Election of Directors: Kapil Dhingra | Withhold | FOR — 5 of 6 Equitable funds | Against | Elected, 84.4% support |
| Replimune Group, Inc. | 2025-09-03 | Election of Directors: Philip Astley-Sparke | Withhold | FOR — 5 of 6 Equitable funds | Against | Elected, 95.9% support |
| First Financial Corporation | 2026-04-15 | Election of Directors: Gregory L. Gibson | Withhold | FOR — 5 of 6 Equitable funds | Against | — |
| First Financial Corporation | 2026-04-15 | Election of Directors: Mark J. Blade | Withhold | FOR — 5 of 6 Equitable funds | Against | — |
| First Financial Corporation | 2026-04-15 | Election of Directors: Norman D. Lowery | Withhold | FOR — 5 of 6 Equitable funds | Against | — |
| First Financial Corporation | 2026-04-15 | Election of Directors: Paul J. Pierson | Withhold | FOR — 5 of 6 Equitable funds | Against | — |
| First Financial Corporation | 2026-04-15 | Election of Directors: Richard J. Shagley | Withhold | FOR — 5 of 6 Equitable funds | Against | — |
| Allogene Therapeutics, Inc. | 2026-06-18 | Election of Directors: Deborah Messemer | Withhold | FOR — 5 of 6 Equitable funds | Against | Elected, 88.6% support |
| Allogene Therapeutics, Inc. | 2026-06-18 | Election of Directors: Owen Witte, M.D. | Withhold | FOR — 5 of 6 Equitable funds | Against | Elected, 82.9% support |
| Allogene Therapeutics, Inc. | 2026-06-18 | Election of Directors: Vicki Sato, Ph.D. | Withhold | FOR — 5 of 6 Equitable funds | Against | Elected, 88.6% support |
| Atea Pharmaceuticals, Inc. | 2026-06-18 | Election of Class III Directors: Barbara Duncan | Withhold | FOR — 5 of 6 Equitable funds | Against | Passed (calculated), 85.6% support |
| Atea Pharmaceuticals, Inc. | 2026-06-18 | Election of Class III Directors: Howard Berman, PhD | Withhold | FOR — 5 of 6 Equitable funds | Against | Passed (calculated), 87.1% support |
| Atea Pharmaceuticals, Inc. | 2026-06-18 | Election of Class III Directors: Jerome Adams, MD, MPH | Withhold | FOR — 5 of 6 Equitable funds | Against | Passed (calculated), 56.4% support |
| Alector, Inc. | 2026-06-17 | ELECTION OF DIRECTORS: Elizabeth Garofalo, M.D. | Withhold | FOR — 5 of 6 Equitable funds | Against | Passed (calculated), 98.5% support |
| Alector, Inc. | 2026-06-17 | ELECTION OF DIRECTORS: Errol De Souza, Ph.D. | Withhold | FOR — 5 of 6 Equitable funds | Against | Passed (calculated), 98.9% support |
| Alector, Inc. | 2026-06-17 | ELECTION OF DIRECTORS: Kristine Yaffe, M.D. | Withhold | FOR — 5 of 6 Equitable funds | Against | Passed (calculated), 74.8% support |
| Rocket Pharmaceuticals, Inc. | 2026-05-20 | The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Carsten Boess | Withhold | FOR — 5 of 6 Equitable funds | Against | Passed (calculated), 99.1% support |
| Rocket Pharmaceuticals, Inc. | 2026-05-20 | The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Fady Malik, M.D., Ph.D. | Withhold | FOR — 5 of 6 Equitable funds | Against | Passed (calculated), 99.2% support |
| Rocket Pharmaceuticals, Inc. | 2026-05-20 | The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Mikael Dolsten, M.D., Ph.D. | Withhold | FOR — 5 of 6 Equitable funds | Against | Passed (calculated), 94.0% support |
| Rocket Pharmaceuticals, Inc. | 2026-05-20 | The election of seven directors named in the proxy statement to hold office until the Company's annual meeting of stockholders in 2027, until their respective successors have been duly elected and qualified or until their earlier death, resignation or removal: Roderick Wong, M.D. | Withhold | FOR — 5 of 6 Equitable funds | Against | Passed (calculated), 99.1% support |
| Codexis, Inc. | 2026-06-17 | Election of the three Class I directors named in the Proxy Statement to hold office for a three-year term expiring at the 2029 Annual Meeting: Rahul Singhvi, Sc.D. | Withhold | FOR — 5 of 6 Equitable funds | Against | Passed (calculated), 98.3% support |
| Codexis, Inc. | 2026-06-17 | Election of the three Class I directors named in the Proxy Statement to hold office for a three-year term expiring at the 2029 Annual Meeting: Raymond De Vre, Ph.D. | Withhold | FOR — 5 of 6 Equitable funds | Against | Passed (calculated), 98.9% support |
| Codexis, Inc. | 2026-06-17 | Election of the three Class I directors named in the Proxy Statement to hold office for a three-year term expiring at the 2029 Annual Meeting: Stephen G. Dilly, M.B.B.S., Ph.D. | Withhold | FOR — 5 of 6 Equitable funds | Against | Passed (calculated), 87.2% support |
| Organogenesis Holdings Inc. | 2026-06-15 | Election of Directors: Jon Giacomin | Withhold | FOR — 5 of 6 Equitable funds | Against | Passed (calculated), 76.0% support |
| Resources Connection, Inc. | 2025-10-16 | Election of Directors: Susan M. Collyns | Against | FOR — 5 of 6 Equitable funds | Against | Elected, 76.0% support |
| Angi Inc. | 2026-06-10 | Approval of the Amended and Restated Angi Inc. 2017 Stock and Annual Incentive Plan. | Against | FOR — 5 of 6 Equitable funds | Against | — |
| Angi Inc. | 2026-06-10 | Election of Class II Directors: Glenn H. Schiffman | For | WITHHOLD — 5 of 6 Equitable funds | For | — |
| Angi Inc. | 2026-06-10 | Election of Class II Directors: Sandra Buchanan | Withhold | FOR — 5 of 6 Equitable funds | Against | — |
| Alphabet Inc. | 2026-06-05 | Election of ten directors: Larry Page | Against | FOR — 15 of 24 Equitable funds | Against | Elected, 97.9% support |
| Alphabet Inc. | 2026-06-05 | Election of ten directors: R. Martin "Marty" Chavez | Against | FOR — 15 of 24 Equitable funds | Against | Elected, 99.0% support |
| Alphabet Inc. | 2026-06-05 | Election of ten directors: Roger W. Ferguson Jr. | Against | FOR — 15 of 24 Equitable funds | Against | Elected, 98.6% support |
| Alphabet Inc. | 2026-06-05 | Election of ten directors: Sergey Brin | Against | FOR — 15 of 24 Equitable funds | Against | Elected, 98.1% support |
| Alphabet Inc. | 2026-06-05 | Election of ten directors: Sundar Pichai | Against | FOR — 15 of 24 Equitable funds | Against | Elected, 98.9% support |
| Meta Platforms, Inc. | 2026-05-27 | Election of Directors: Robert M. Kimmitt | Withhold | FOR — 15 of 24 Equitable funds | Against | Elected, 97.1% support |
| Sempra | 2026-05-12 | Advisory approval of our executive compensation. | Against | FOR — 13 of 20 Equitable funds | Against | Passed (calculated), 87.5% support |
| Illumina, Inc. | 2026-05-21 | To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement. | Against | FOR — 8 of 11 Equitable funds | Against | Passed (calculated), 93.5% support |
| DoorDash, Inc. | 2026-06-10 | The election of the following director nominee(s): Alfred Lin | Against | FOR — 10 of 15 Equitable funds | Against | Elected, 93.8% support |
| DoorDash, Inc. | 2026-06-10 | The election of the following director nominee(s): Stanley Tang | Against | FOR — 10 of 15 Equitable funds | Against | Elected, 94.0% support |
| Axon Enterprise, Inc. | 2026-05-28 | Election of nine directors of the Company named in the proxy statement: Caitlin Kalinowski | Against | FOR — 10 of 15 Equitable funds | Against | Elected, 98.5% support |
| Axon Enterprise, Inc. | 2026-05-28 | Election of nine directors of the Company named in the proxy statement: Graham Smith | Against | FOR — 10 of 15 Equitable funds | Against | Elected, 97.5% support |
| Axon Enterprise, Inc. | 2026-05-28 | Election of nine directors of the Company named in the proxy statement: Michael Garnreiter | Against | FOR — 10 of 15 Equitable funds | Against | Elected, 91.6% support |
| Lennar Corporation | 2026-04-08 | Elect nine directors to serve until the 2027 Annual Meeting of Stockholders: Amy Banse | Against | FOR — 10 of 15 Equitable funds | Against | Elected, 96.6% support |
| Lennar Corporation | 2026-04-08 | Elect nine directors to serve until the 2027 Annual Meeting of Stockholders: Armando Olivera | Against | FOR — 10 of 15 Equitable funds | Against | Elected, 97.5% support |
| Lennar Corporation | 2026-04-08 | Elect nine directors to serve until the 2027 Annual Meeting of Stockholders: Dacona Smith | Against | FOR — 10 of 15 Equitable funds | Against | Elected, 98.2% support |
| Lennar Corporation | 2026-04-08 | Elect nine directors to serve until the 2027 Annual Meeting of Stockholders: Jeffrey Sonnenfeld | Against | FOR — 10 of 15 Equitable funds | Against | Elected, 84.2% support |
| Lennar Corporation | 2026-04-08 | Elect nine directors to serve until the 2027 Annual Meeting of Stockholders: Serena Wolfe | Against | FOR — 10 of 15 Equitable funds | Against | Elected, 99.3% support |
| Lennar Corporation | 2026-04-08 | Elect nine directors to serve until the 2027 Annual Meeting of Stockholders: Sherrill W. Hudson | Against | FOR — 10 of 15 Equitable funds | Against | Elected, 94.3% support |
| Lennar Corporation | 2026-04-08 | Elect nine directors to serve until the 2027 Annual Meeting of Stockholders: Stuart Miller | Against | FOR — 10 of 15 Equitable funds | Against | Elected, 89.5% support |
| Lennar Corporation | 2026-04-08 | Elect nine directors to serve until the 2027 Annual Meeting of Stockholders: Teri P. McClure | Against | FOR — 10 of 15 Equitable funds | Against | Elected, 95.6% support |
| Lennar Corporation | 2026-04-08 | Elect nine directors to serve until the 2027 Annual Meeting of Stockholders: Theron (Tig) Gilliam | Against | FOR — 10 of 15 Equitable funds | Against | Elected, 96.9% support |
| Alphabet Inc. | 2026-06-05 | Shareholder Shareholder proposal regarding an enhanced disclosure on climate goals | For | AGAINST — 15 of 25 Equitable funds | Against | Not approved, 7.4% support |
| Alphabet Inc. | 2026-06-05 | Election of ten directors: K. Ram Shriram | Against | FOR — 15 of 25 Equitable funds | Against | Elected, 95.2% support |
| Palo Alto Networks, Inc. | 2025-12-09 | Election of Class II Directors: John M. Donovan | Against | FOR — 12 of 19 Equitable funds | Against | Elected, 78.9% support |
| Thermo Fisher Scientific Inc. | 2026-05-20 | Election of Directors: Dion J. Weisler | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 89.5% support |
| Prologis, Inc. | 2026-04-28 | Advisory Vote to Approve the Company's Executive Compensation for 2025. | Against | FOR — 11 of 17 Equitable funds | Against | Passed (calculated), 58.3% support |
| Prologis, Inc. | 2026-04-28 | Election of Directors: George L. Fotiades | Against | FOR — 11 of 17 Equitable funds | Against | Passed (calculated), 87.8% support |
| Phillips 66 | 2026-05-13 | Election of four Class III Directors named in this Proxy Statement to hold office until the 2029 Annual Meeting: Gregory J. Hayes | Against | FOR — 13 of 21 Equitable funds | Against | Passed (calculated), 91.2% support |
| Regeneron Pharmaceuticals, Inc. | 2026-06-12 | Election of Directors: Craig B. Thompson, M.D. | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 79.3% support |
| Regeneron Pharmaceuticals, Inc. | 2026-06-12 | Election of Directors: David P. Schenkein, M.D. | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 96.0% support |
| Regeneron Pharmaceuticals, Inc. | 2026-06-12 | Election of Directors: Huda Y. Zoghbi, M.D. | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 97.4% support |
| Regeneron Pharmaceuticals, Inc. | 2026-06-12 | Election of Directors: Joseph L. Goldstein, M.D. | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 70.1% support |
| Datadog, Inc. | 2026-06-15 | To elect four Class I directors, each to hold office until our Annual Meeting of Stockholders in 2029: Dev Ittycheria | Withhold | FOR — 12 of 19 Equitable funds | Against | Elected, 88.8% support |
| Datadog, Inc. | 2026-06-15 | To elect four Class I directors, each to hold office until our Annual Meeting of Stockholders in 2029: Shardul Shah | Withhold | FOR — 12 of 19 Equitable funds | Against | Elected, 83.8% support |
| Workday, Inc. | 2026-06-16 | Election of Class II Directors: Mark J. Hawkins | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 93.4% support |
| Workday, Inc. | 2026-06-16 | Election of Class II Directors: Rhonda J. Morris | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 99.3% support |
| Baker Hughes Company | 2026-05-19 | The Election of Directors: Cynthia B. Carroll | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 95.5% support |
| Live Nation Entertainment, Inc. | 2026-06-11 | To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Carl Vogel | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 99.8% support |
| Live Nation Entertainment, Inc. | 2026-06-11 | To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Chad Hollingsworth | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 94.9% support |
| Live Nation Entertainment, Inc. | 2026-06-11 | To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: James Iovine | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 98.4% support |
| Live Nation Entertainment, Inc. | 2026-06-11 | To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: James S. Kahan | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 98.8% support |
| Live Nation Entertainment, Inc. | 2026-06-11 | To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Jeffrey T. Hinson | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 98.6% support |
| Live Nation Entertainment, Inc. | 2026-06-11 | To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Latriece Watkins | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 98.4% support |
| Live Nation Entertainment, Inc. | 2026-06-11 | To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Ping Fu | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 99.6% support |
| Live Nation Entertainment, Inc. | 2026-06-11 | To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Randall T. Mays | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 97.0% support |
| Live Nation Entertainment, Inc. | 2026-06-11 | To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Richard A. Grenell | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 99.8% support |
| Live Nation Entertainment, Inc. | 2026-06-11 | To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Richard A. Paul | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 99.7% support |
| Live Nation Entertainment, Inc. | 2026-06-11 | To hold an advisory vote on the company's executive compensation; | Against | FOR — 11 of 17 Equitable funds | Against | Passed (calculated), 86.8% support |
| The Hartford Insurance Group, Inc. | 2026-05-20 | Shareholder Shareholder proposal that the Company adopt written consent rights for shareholders | For | AGAINST — 11 of 17 Equitable funds | Against | Not approved, 45.2% support |
| SBA Communications Corporation | 2026-05-22 | Election of Directors: Amy E. Wilson | Against | FOR — 11 of 17 Equitable funds | Against | Passed (calculated), 92.4% support |
| SBA Communications Corporation | 2026-05-22 | Election of Directors: Laurie Bowen | Against | FOR — 11 of 17 Equitable funds | Against | Passed (calculated), 88.6% support |
| SBA Communications Corporation | 2026-05-22 | Election of Directors: Steven E. Bernstein | Against | FOR — 11 of 17 Equitable funds | Against | Passed (calculated), 94.3% support |
| Tractor Supply Company | 2026-05-14 | To approve, on a non-binding, advisory basis, the compensation of the named executive officers of the Company (Say on Pay) | Against | FOR — 12 of 19 Equitable funds | Against | Approved, 86.0% support |
| Revvity, Inc. | 2026-04-28 | Shareholder To approve the shareholder proposal regarding Executives to Retain Significant Stock. | For | AGAINST — 11 of 17 Equitable funds | Against | Failed (calculated), 23.1% support |
| IDEX Corporation | 2026-05-06 | Election of four directors named in the proxy statement as follows: Alejandro Quiroz Centeno | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 98.8% support |
| IDEX Corporation | 2026-05-06 | Election of four directors named in the proxy statement as follows: Carl R. Christenson | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 95.9% support |
| IDEX Corporation | 2026-05-06 | Election of four directors named in the proxy statement as follows: Katrina L. Helmkamp | Against | FOR — 11 of 17 Equitable funds | Against | Elected, 97.7% support |
| IDEX Corporation | 2026-05-06 | Election of four directors named in the proxy statement as follows: Mark A. Beck | Against | FOR — 11 of 17 Equitable funds | Against | Passed (calculated), 93.5% support |
| Red Rock Resorts, Inc. | 2026-06-04 | Advisory vote to approve the compensation of our named executive officers. | Against | FOR — 6 of 8 Equitable funds | Against | — |
| PotlatchDeltic Corporation | 2026-01-27 | The PotlatchDeltic adjournment proposal: A proposal to adjourn the special meeting from time to time, if necessary or appropriate, to solicit additional proxies in the event there are not sufficient votes at the time of the special meeting to approve the PotlatchDeltic merger agreement proposal. | Abstain | FOR — 6 of 8 Equitable funds | Against | — |
| PotlatchDeltic Corporation | 2026-01-27 | The PotlatchDeltic merger agreement proposal: A proposal to adopt the Agreement and Plan of Merger (as it may be amended from time to time, the "merger agreement"), dated as of October 13, 2025, by and among PotlatchDeltic Corporation ("PotlatchDeltic"), Rayonier Inc. ("Rayonier"), and Redwood Merge | Abstain | FOR — 6 of 8 Equitable funds | Against | Approved, 99.9% support |
| Alphabet Inc. | 2026-06-05 | Shareholder Shareholder proposal regarding a report on AI-generated misinformation | For | AGAINST or ABSTAIN — 14 of 24 Equitable funds | Against | Not approved, 9.3% support |
| Alphabet Inc. | 2026-06-05 | Election of ten directors: Frances H. Arnold | Against | FOR — 14 of 24 Equitable funds | Against | Elected, 90.1% support |
| Tesla, Inc. | 2025-11-06 | A Tesla proposal for approval of the A&R 2019 Equity Incentive Plan. | Against | FOR — 13 of 22 Equitable funds | Against | Approved, 79.1% support |
| Cisco Systems, Inc. | 2025-12-16 | Election of Directors: Daniel H. Schulman | Against | FOR — 11 of 18 Equitable funds | Against | Passed (calculated), 90.6% support |
| NextEra Energy, Inc. | 2026-05-21 | Approval, by non-binding advisory vote, of NextEra Energy's compensation of its named executive officers as disclosed in the proxy statement. | Against | FOR — 11 of 18 Equitable funds | Against | Approved, 88.2% support |
| Salesforce, Inc. | 2026-05-28 | Approval, on an advisory basis, of the fiscal 2026 compensation of our named executive officers. | Against | FOR — 11 of 18 Equitable funds | Against | Passed (calculated), 80.8% support |
| BlackRock, Inc. | 2026-05-20 | Approval, in a non-binding advisory vote, of the compensation for named executive officers. | Against | FOR — 9 of 14 Equitable funds | Against | Passed (calculated), 65.0% support |
| The Charles Schwab Corporation | 2026-05-21 | Election of directors for three-year terms: Frank C. Herringer | Against | FOR — 13 of 22 Equitable funds | Against | Elected, 84.3% support |
| Booking Holdings Inc. | 2026-06-02 | Shareholder Non-binding stockholder vote on a proposal to avoid brand damage due to corporate political spending. | For | AGAINST — 12 of 20 Equitable funds | Against | Not approved, 35.2% support |
| AppLovin Corporation | 2026-06-03 | Election of Directors: EDUARDO VIVAS | Withhold | FOR — 10 of 16 Equitable funds | Against | Passed (calculated), 95.6% support |
| Moderna, Inc. | 2026-05-06 | To elect two Class II director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Ab | Against | FOR — 10 of 16 Equitable funds | Against | Elected, 98.5% support |
| Adobe Inc. | 2026-04-15 | Election of the eleven (11) Directors proposed in the accompanying Proxy Statement to serve for a one-year term: Frank Calderoni | Against | FOR — 10 of 16 Equitable funds | Against | Passed (calculated), 88.6% support |
| The Cigna Group | 2026-04-22 | Shareholder Shareholder Proposal - Shareholder Right to Act by Written Consent | For | AGAINST — 11 of 18 Equitable funds | Against | Failed (calculated), 47.9% support |
| Carvana Co. | 2026-05-05 | Shareholder To vote upon one stockholder proposal, as described in the Proxy Statement. | For | AGAINST — 10 of 16 Equitable funds | Against | Not approved, 3.9% support |
| DoorDash, Inc. | 2026-06-10 | The election of the following director nominee(s): Shona L. Brown | Against | FOR — 10 of 16 Equitable funds | Against | Elected, 89.8% support |
| Hewlett Packard Enterprise Company | 2026-04-01 | Advisory vote to approve the Hewlett Packard Enterprise Company's executive compensation | Against | FOR — 11 of 18 Equitable funds | Against | Passed (calculated), 73.7% support |
| Workday, Inc. | 2026-06-16 | Election of Class II Directors: George J. Still, Jr. | Against | FOR — 11 of 18 Equitable funds | Against | Elected, 97.0% support |
| Zoetis Inc. | 2026-05-20 | Shareholder Shareholder proposal to permit shareholder action by written consent. | For | AGAINST — 12 of 20 Equitable funds | Against | — |
| Dollar General Corporation | 2026-05-28 | Shareholder To vote on a shareholder proposal asking the Board to take the steps necessary to reduce the minimum ownership percentage required to call a special shareholders' meeting from 25% to 10%. | For | AGAINST — 10 of 16 Equitable funds | Against | Not approved, 42.4% support |
| Corpay, Inc. | 2026-05-07 | Shareholder Shareholder proposal regarding an independent Board Chair requirement, if properly presented at the meeting. | For | AGAINST — 10 of 16 Equitable funds | Against | Failed (calculated), 30.0% support |
| Ralph Lauren Corporation | 2025-07-31 | Approval, on an advisory basis, of the compensation of our named executive officers and our compensation philosophy, policies and practices as described in the accompanying Proxy Statement. | Against | FOR — 10 of 16 Equitable funds | Against | Passed (calculated), 99.2% support |
| Ralph Lauren Corporation | 2025-07-31 | Election of three (3) Class A Directors. Nominees as Class A Directors: Linda Findley | Withhold | FOR — 10 of 16 Equitable funds | Against | Passed (calculated), 96.5% support |
| KeyCorp | 2026-05-14 | Advisory approval of executive compensation. | Against | FOR — 10 of 16 Equitable funds | Against | Passed (calculated), 92.4% support |
| Masco Corporation | 2026-05-08 | Shareholder Consideration of stockholder proposal on shareholder right to call a special meeting. | For | AGAINST — 10 of 16 Equitable funds | Against | — |
| Trimble Inc. | 2026-05-26 | Election of Directors: Borje Ekholm | Withhold | FOR — 10 of 16 Equitable funds | Against | Elected, 94.0% support |
| Trimble Inc. | 2026-05-26 | Election of Directors: Johan Wibergh | Withhold | FOR — 10 of 16 Equitable funds | Against | Elected, 95.5% support |
| Trimble Inc. | 2026-05-26 | Election of Directors: Ronald S. Nersesian | Withhold | FOR — 10 of 16 Equitable funds | Against | Elected, 98.4% support |
| FactSet Research Systems Inc. | 2025-12-18 | To approve the FactSet Research Systems Inc. 2025 Omnibus Incentive Plan. | Against | FOR — 12 of 20 Equitable funds | Against | — |
| FactSet Research Systems Inc. | 2025-12-18 | To elect ten directors to the Board of Directors: Robin A. Abrams, Siew Kai Choy, Barak Eilam, Malcolm Frank, Laurie G. Hylton, Lee Shavel, Laurie Siegel, Maria Teresa Tejada, Sanoke Viswanathan, and Elisha Wiesel each be elected to serve a one-year term expiring in concurrence with the Annual Meeti | Against | FOR — 12 of 20 Equitable funds | Against | Elected, 94.1% support |
| FactSet Research Systems Inc. | 2025-12-18 | To elect ten directors to the Board of Directors: Robin A. Abrams, Siew Kai Choy, Barak Eilam, Malcolm Frank, Laurie G. Hylton, Lee Shavel, Laurie Siegel, Maria Teresa Tejada, Sanoke Viswanathan, and Elisha Wiesel each be elected to serve a one-year term expiring in concurrence with the Annual Meeti | Against | FOR — 12 of 20 Equitable funds | Against | Elected, 98.2% support |
| FactSet Research Systems Inc. | 2025-12-18 | To elect ten directors to the Board of Directors: Robin A. Abrams, Siew Kai Choy, Barak Eilam, Malcolm Frank, Laurie G. Hylton, Lee Shavel, Laurie Siegel, Maria Teresa Tejada, Sanoke Viswanathan, and Elisha Wiesel each be elected to serve a one-year term expiring in concurrence with the Annual Meeti | Against | FOR — 12 of 20 Equitable funds | Against | Elected, 98.2% support |
| FactSet Research Systems Inc. | 2025-12-18 | To elect ten directors to the Board of Directors: Robin A. Abrams, Siew Kai Choy, Barak Eilam, Malcolm Frank, Laurie G. Hylton, Lee Shavel, Laurie Siegel, Maria Teresa Tejada, Sanoke Viswanathan, and Elisha Wiesel each be elected to serve a one-year term expiring in concurrence with the Annual Meeti | Against | FOR — 12 of 20 Equitable funds | Against | Elected, 98.1% support |
| Lennox International Inc. | 2026-05-21 | To elect three Class I directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders: Karen H. Quintos | Against | FOR — 10 of 16 Equitable funds | Against | Passed (calculated), 93.2% support |
| Align Technology, Inc. | 2026-05-20 | Advisory Vote to Approve the Compensation of our Named Executive Officers | Against | FOR — 10 of 16 Equitable funds | Against | Passed (calculated), 89.4% support |
| Align Technology, Inc. | 2026-05-20 | Ratification of Special Meeting Provision in our Bylaws | Against | FOR — 10 of 16 Equitable funds | Against | Passed (calculated), 73.7% support |
| The AES Corporation | 2026-04-29 | Shareholder If properly presented, to vote on a non-binding stockholder proposal regarding stockholder ability to call a special meeting. | For | AGAINST — 10 of 16 Equitable funds | Against | Failed (calculated), 34.8% support |
| A. O. Smith Corporation | 2026-04-13 | Election of directors: Lois M. Martin | Withhold | FOR — 10 of 16 Equitable funds | Against | Passed (calculated), 90.8% support |
| Krystal Biotech, Inc. | 2026-05-15 | Election of Class III Directors: Christopher Mason | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 84.0% support |
| Krystal Biotech, Inc. | 2026-05-15 | Election of Class III Directors: Krish S. Krishnan | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 88.5% support |
| GRAIL, Inc. | 2026-06-18 | Election of Class II Directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successor has been duly elected and qualified: Steven Mizell | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 77.6% support |
| UniFirst Corporation | 2026-06-11 | To adjourn the special meeting of UniFirst shareholders to a later date or dates, if necessary or appropriate, to solicit additional proxies if, immediately prior to such adjournment, there are not sufficient votes at the time of the UniFirst special meeting to approve the UniFirst merger proposal o | Abstain | FOR — 4 of 5 Equitable funds | Against | — |
| Cathay General Bancorp | 2026-05-18 | 4 wordings Election of Class III Directors, to be elected for the term ending 2029: Nelson Chung | Against | FOR — 4 of 5 Equitable funds | Against | Elected, 92.7% support |
| Provident Financial Services, Inc. | 2026-05-21 | The election as directors of all nominees listed below (except as marked to the contrary on the right), each for a three-year term: Brian A. Gragnolati | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 97.9% support |
| Provident Financial Services, Inc. | 2026-05-21 | The election as directors of all nominees listed below (except as marked to the contrary on the right), each for a three-year term: Edward J. Leppert | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 95.9% support |
| Provident Financial Services, Inc. | 2026-05-21 | The election as directors of all nominees listed below (except as marked to the contrary on the right), each for a three-year term: Nadine Leslie | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 97.9% support |
| Provident Financial Services, Inc. | 2026-05-21 | The election as directors of all nominees listed below (except as marked to the contrary on the right), each for a three-year term: Thomas J. Shara | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 97.5% support |
| Surgery Partners, Inc. | 2026-06-05 | Election of Class II Directors: Brent Turner | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 96.9% support |
| Surgery Partners, Inc. | 2026-06-05 | Election of Class II Directors: Devin O'Reilly | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 79.2% support |
| Surgery Partners, Inc. | 2026-06-05 | Election of Class II Directors: Laura L. Forese, M.D. | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 80.2% support |
| IDEAYA Biosciences, Inc. | 2026-06-16 | To elect three Class I directors to hold office until the 2029 annual meeting of stockholders or until their successors are elected: Catherine J. Mackey, Ph.D. | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 96.3% support |
| IDEAYA Biosciences, Inc. | 2026-06-16 | To elect three Class I directors to hold office until the 2029 annual meeting of stockholders or until their successors are elected: M. Garret Hampton, Ph.D. | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 77.7% support |
| IDEAYA Biosciences, Inc. | 2026-06-16 | To elect three Class I directors to hold office until the 2029 annual meeting of stockholders or until their successors are elected: Yujiro S. Hata | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 96.6% support |
| ArcBest Corporation | 2026-04-24 | Shareholder A shareholder proposal to approve GHG emissions reduction targets, if properly presented at the Annual Meeting. | For | AGAINST — 4 of 5 Equitable funds | Against | — |
| Xencor, Inc. | 2026-06-16 | Approval of the amendment to the Company's Amended and Restated 2023 Equity Incentive Plan to increase the number of authorized shares reserved for issuance thereunder by 4,000,000 shares; and | Against | FOR — 4 of 5 Equitable funds | Against | Approved, 82.0% support |
| Neogen Corporation | 2025-10-23 | To Approve, On An Advisory Basis, The Compensation of Named Executive Officers. | Against | FOR — 4 of 5 Equitable funds | Against | Approved, 90.4% support |
| Peloton Interactive, Inc. | 2025-12-09 | Election of Directors: Karen Boone | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 98.1% support |
| Peloton Interactive, Inc. | 2025-12-09 | Election of Directors: Tara Comonte | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 99.1% support |
| Maravai Lifesciences Holdings, Inc. | 2026-05-26 | To approve, on a non-binding advisory basis, the compensation of Maravai's named executive officers. | Against | FOR — 4 of 5 Equitable funds | Against | Approved, 98.8% support |
| Maravai Lifesciences Holdings, Inc. | 2026-05-26 | To elect three nominees to the Board of Directors (3-year term expiring in 2029): Gregory T. Lucier | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 88.5% support |
| Maravai Lifesciences Holdings, Inc. | 2026-05-26 | To elect three nominees to the Board of Directors (3-year term expiring in 2029): Luke Marker | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 89.9% support |
| Omnicell, Inc. | 2026-05-19 | Proposal to elect Class I Directors to hold office until the 2029 Annual Meeting of Stockholders: Eileen J. Voynick | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 93.0% support |
| Omnicell, Inc. | 2026-05-19 | Proposal to elect Class I Directors to hold office until the 2029 Annual Meeting of Stockholders: Joanne B. Bauer | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 89.6% support |
| Omnicell, Inc. | 2026-05-19 | Proposal to elect Class I Directors to hold office until the 2029 Annual Meeting of Stockholders: Robin G. Seim | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 90.9% support |
| Diversified Healthcare Trust | 2026-06-10 | 6 wordings Election of Trustees. Nominees (for Independent Trustee): Alan Felder | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 98.0% support |
| Agios Pharmaceuticals, Inc. | 2026-06-18 | To elect each of the three Class I director nominees set forth in the Proxy Statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her respective successor is duly elected and qualified: Rahul Ballal, Ph.D. | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 87.1% support |
| Distribution Solutions Group, Inc. | 2026-05-14 | Election of seven directors to serve one year: Bianca A. Rhodes | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 93.1% support |
| Distribution Solutions Group, Inc. | 2026-05-14 | Election of seven directors to serve one year: I. Steven Edelson | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 93.9% support |
| Distribution Solutions Group, Inc. | 2026-05-14 | Election of seven directors to serve one year: Lee S. Hillman | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 94.0% support |
| Distribution Solutions Group, Inc. | 2026-05-14 | Election of seven directors to serve one year: M. Bradley Wallace | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 92.6% support |
| Distribution Solutions Group, Inc. | 2026-05-14 | Election of seven directors to serve one year: Mark F. Moon | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 90.3% support |
| Distribution Solutions Group, Inc. | 2026-05-14 | Election of seven directors to serve one year: Robert S. Zamarripa | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 94.1% support |
| Live Oak Bancshares, Inc. | 2026-05-19 | Election of Directors: David G. Lucht | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 86.0% support |
| Live Oak Bancshares, Inc. | 2026-05-19 | Election of Directors: James S. Mahan III | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 96.2% support |
| Live Oak Bancshares, Inc. | 2026-05-19 | Election of Directors: Miltom E. Petty | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 78.9% support |
| Live Oak Bancshares, Inc. | 2026-05-19 | Election of Directors: Neil L. Underwood | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 94.2% support |
| Live Oak Bancshares, Inc. | 2026-05-19 | Election of Directors: Patrick T. McHenry | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 99.0% support |
| Live Oak Bancshares, Inc. | 2026-05-19 | Election of Directors: Tonya W. Bradford | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 92.2% support |
| Live Oak Bancshares, Inc. | 2026-05-19 | Election of Directors: William H. Cameron | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 74.7% support |
| Live Oak Bancshares, Inc. | 2026-05-19 | Election of Directors: William L. Williams III | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 94.4% support |
| Live Oak Bancshares, Inc. | 2026-05-19 | Election of Directors: Yousef A. Valine | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 78.3% support |
| Pacira Biosciences, Inc. | 2026-06-09 | Approval of our Amended and Restated 2011 Stock Incentive Plan. | Against | FOR — 4 of 5 Equitable funds | Against | Failed (calculated), 43.5% support |
| Pacira Biosciences, Inc. | 2026-06-09 | Approval, on an advisory basis, of the compensation of our named executive officers. | Against | FOR — 4 of 5 Equitable funds | Against | — |
| Phibro Animal Health Corporation | 2025-11-04 | Election of Class III Directors: Alejandro Bernal | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 97.2% support |
| Tennant Company | 2026-04-29 | Elect three Class I directors to three-year terms: Carol S. Eicher | Against | FOR — 4 of 5 Equitable funds | Against | Elected, 97.3% support |
| Tennant Company | 2026-04-29 | Elect three Class I directors to three-year terms: Donal L. Mulligan | Against | FOR — 4 of 5 Equitable funds | Against | Elected, 97.2% support |
| Tennant Company | 2026-04-29 | Elect three Class I directors to three-year terms: Maria C. Green | Against | FOR — 4 of 5 Equitable funds | Against | Elected, 96.2% support |
| Amphastar Pharmaceuticals, Inc. | 2026-06-01 | To elect three Class I directors to serve until the Company's 2029 annual meeting of stockholders and until each such director's successor is elected and qualified or until such director's earlier death, resignation or removal: Jacob Liawatidewi | Against | FOR — 4 of 5 Equitable funds | Against | Elected, 65.5% support |
| PROCEPT BioRobotics Corporation | 2026-06-09 | Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. | Against | FOR — 4 of 5 Equitable funds | Against | Approved, 73.1% support |
| PROCEPT BioRobotics Corporation | 2026-06-09 | 3 wordings Election of Class II directors to serve until 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Antal Desai | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 77.0% support |
| Castle Biosciences, Inc. | 2026-05-28 | To elect the three Class I director nominees listed below to hold office until the 2029 Annual Meeting of Stockholders: Ellen Goldberg | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 68.5% support |
| Castle Biosciences, Inc. | 2026-05-28 | To elect the three Class I director nominees listed below to hold office until the 2029 Annual Meeting of Stockholders: Miles D. Harrison | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 69.1% support |
| Castle Biosciences, Inc. | 2026-05-28 | To elect the three Class I director nominees listed below to hold office until the 2029 Annual Meeting of Stockholders: Tiffany P. Olson | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 63.7% support |
| Playtika Holding Corp. | 2026-06-11 | Election of Six Directors: Bing Yuan | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 94.1% support |
| Playtika Holding Corp. | 2026-06-11 | Election of Six Directors: Dana Gross | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 99.3% support |
| Playtika Holding Corp. | 2026-06-11 | Election of Six Directors: Hong Du | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 98.6% support |
| Playtika Holding Corp. | 2026-06-11 | Election of Six Directors: Marc Beilinson | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 94.6% support |
| Playtika Holding Corp. | 2026-06-11 | Election of Six Directors: Tian Lin | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 99.6% support |
| Fox Factory Holding Corp. | 2026-05-08 | Election of Directors (term expires in 2029): Elizabeth A. Fetter | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 87.6% support |
| Fox Factory Holding Corp. | 2026-05-08 | To approve, on an advisory basis, the resolution approving the compensation of Fox Factory Holding Corp.'s named executive officers. | Against | FOR — 4 of 5 Equitable funds | Against | Approved, 88.3% support |
| Hertz Global Holdings, Inc. | 2026-05-28 | Approval, on an advisory basis, of the compensation of our named executive officers. | Against | FOR — 4 of 5 Equitable funds | Against | Approved, 98.3% support |
| Kearny Financial Corp. | 2025-10-21 | The election of the five nominees listed, for the term indicated: Christopher Petermann, three-year term | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 88.4% support |
| Kearny Financial Corp. | 2025-10-21 | The election of the five nominees listed, for the term indicated: John F. McGovern, three-year term | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 86.2% support |
| Kearny Financial Corp. | 2025-10-21 | The election of the five nominees listed, for the term indicated: John J. Mazur, Jr., three-year term | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 82.9% support |
| Kearny Financial Corp. | 2025-10-21 | The election of the five nominees listed, for the term indicated: Melvina Wong-Zaza, two-year term | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 96.0% support |
| Kearny Financial Corp. | 2025-10-21 | The election of the five nominees listed, for the term indicated: Raymond E. Chandonnet, three-year term | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 95.1% support |
| NRC Health | 2026-06-23 | APPROVAL OF AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO CHANGE THE VOTING REQUIREMENT FOR STOCKHOLDER ACTION BY WRITTEN CONSENT IN LIEU OF A MEETING FROM UNANIMOUS TO THE VOTING POWER THAT WOULD BE REQUIRED TO GIVE EFFECT TO THE ACTION IF IT WERE APPROVED AT A MEETING, ALONG WITH CERTAIN CLA | For | AGAINST — 4 of 5 Equitable funds | For | Approved, 94.8% support |
| NRC Health | 2026-06-23 | APPROVAL OF AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO REMOVE CERTAIN SUPERMAJORITY VOTING REQUIREMENTS IN ARTICLE 6 OF OUR CERTIFICATE OF INCORPORATION, ALONG WITH CERTAIN CLARIFYING, CONFORMING, AND MINISTERIAL CHANGES. | For | AGAINST — 4 of 5 Equitable funds | For | Approved, 95.1% support |
| NRC Health | 2026-06-23 | NON-BINDING, ADVISORY VOTE ON THE APPROVAL OF THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT. | Against | FOR — 4 of 5 Equitable funds | Against | Approved, 85.5% support |
| Arvinas, Inc. | 2026-06-24 | Election of two Class II directors: Leslie V. Norwalk, Esq. | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 75.8% support |
| Prothena Corporation plc | 2026-05-14 | To elect, by separate resolutions, two directors to hold office until no later than the Annual General Meeting of the Company's Shareholders in 2029, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company: Dennis J. Selkoe | Against | FOR — 4 of 5 Equitable funds | Against | Elected, 72.8% support |
| Prothena Corporation plc | 2026-05-14 | To elect, by separate resolutions, two directors to hold office until no later than the Annual General Meeting of the Company's Shareholders in 2029, unless they resign, are removed from office, or are otherwise disqualified from serving as directors of the Company: Shane M. Cooke | Against | FOR — 4 of 5 Equitable funds | Against | Elected, 65.6% support |
| Editas Medicine, Inc. | 2026-06-17 | Election of two Class I Directors, each to serve until the 2029 annual meeting of stockholders: Elliott Levy, M.D. | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 94.0% support |
| Editas Medicine, Inc. | 2026-06-17 | To approve, on an advisory basis, the compensation paid to the Company's named executive officers. | Against | FOR — 4 of 5 Equitable funds | Against | Approved, 83.9% support |
| ChargePoint Holdings, Inc. | 2025-07-08 | 4 wordings Election of Class II directors: Mitesh Dhruv | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 92.2% support |
| ChargePoint Holdings, Inc. | 2025-07-08 | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement; | Against | FOR — 4 of 5 Equitable funds | Against | — |
| MBIA Inc. | 2026-05-05 | Election of Directors: Janice L. Innis-Thompson | Against | FOR — 4 of 5 Equitable funds | Against | — |
| MBIA Inc. | 2026-05-05 | Election of Directors: Richard C. Vaughan | Against | FOR — 4 of 5 Equitable funds | Against | — |
| MBIA Inc. | 2026-05-05 | Election of Directors: Steven J. Gilbert | Against | FOR — 4 of 5 Equitable funds | Against | — |
| MBIA Inc. | 2026-05-05 | Election of Directors: Theodore Shasta | Against | FOR — 4 of 5 Equitable funds | Against | — |
| MBIA Inc. | 2026-05-05 | Election of Directors: William C. Fallon | Against | FOR — 4 of 5 Equitable funds | Against | — |
| MBIA Inc. | 2026-05-05 | To approve, on an advisory basis, executive compensation. | Against | FOR — 4 of 5 Equitable funds | Against | — |
| Fate Therapeutics, Inc. | 2026-06-12 | Election of Class I Directors: Karin Jooss, Ph.D. | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 97.7% support |
| Fate Therapeutics, Inc. | 2026-06-12 | Election of Class I Directors: Robert S. Epstein, M.D., M.S. | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 97.2% support |
| Fate Therapeutics, Inc. | 2026-06-12 | To approve a proposal to amend and restate the Company's 2022 Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder. | Against | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 76.5% support |
| SITE Centers Corp. | 2026-05-13 | Election of Directors: David R. Lukes | Against | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 96.3% support |
| Inogen, Inc. | 2026-06-05 | To approve the Inogen, Inc. Amended and Restated 2023 Equity Incentive Plan. | Against | FOR — 4 of 5 Equitable funds | Against | Approved, 89.0% support |
| Nkarta, Inc. | 2026-06-10 | Election of two directors to serve until the company's 2029 annual meeting of stockholders and until their respective successors are duly elected and qualified: Zachary Scheiner, Ph.D. | Withhold | FOR — 4 of 5 Equitable funds | Against | Elected, 79.7% support |
| Cable One, Inc. | 2026-05-14 | Election of Directors: Katharine B. Weymouth | Against | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 96.7% support |
| Select Medical Holdings Corporation | 2026-04-23 | Shareholder Non-Binding Advisory Vote on a Stockholder Proposal to provide stockholders the right to call a special meeting of stockholders at a 10% ownership threshold, if properly presented at the meeting. | For | AGAINST — 4 of 5 Equitable funds | Against | Failed (calculated), 20.0% support |
| Avanos Medical, Inc. | 2026-04-21 | Advisory vote to approve named executive officer compensation. | Against | FOR — 4 of 5 Equitable funds | Against | — |
| Brookfield Business Corporation | 2026-01-13 | Approve BBUC Arrangement Resolution | Against | FOR — 4 of 5 Equitable funds | Against | — |
| Brookfield Business Corporation | 2026-06-18 | Elect Director Cyrus Madon | Withhold | FOR — 4 of 5 Equitable funds | Against | — |
| Brookfield Business Corporation | 2026-06-18 | Elect Director David Court | Withhold | FOR — 4 of 5 Equitable funds | Against | — |
| Brookfield Business Corporation | 2026-06-18 | Elect Director Jeffrey Blidner | Withhold | FOR — 4 of 5 Equitable funds | Against | — |
| Brookfield Business Corporation | 2026-06-18 | Elect Director Lori Pearson | Withhold | FOR — 4 of 5 Equitable funds | Against | — |
| Brookfield Business Corporation | 2026-06-18 | Elect Director Patricia Zuccotti | Withhold | FOR — 4 of 5 Equitable funds | Against | — |
| Brookfield Business Corporation | 2026-06-18 | Elect Director Stephen Girsky | Withhold | FOR — 4 of 5 Equitable funds | Against | — |
| DigitalBridge Group, Inc. | 2026-05-28 | To approve, on a non-binding, advisory basis, named executive officer compensation | Against | FOR — 4 of 5 Equitable funds | Against | Approved, 60.1% support |
| Enhabit, Inc. | 2026-05-12 | Approval, on a non-binding, advisory basis, certain compensation that may be paid or become payable to Enhabit's named executive officers that is based on or otherwise relates to the Merger. | Against | FOR — 4 of 5 Equitable funds | Against | — |
| Hillenbrand, Inc. | 2026-01-08 | Proposal to approve, on an advisory (nonbinding) basis, the compensation that may be paid or become payable to Hillenbrand, Inc.'s named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement (the "Compensation Propo | Against | FOR — 4 of 5 Equitable funds | Against | — |
| InnovAge Holding Corp. | 2025-12-04 | Election of Class II Directors: Richard Zoretic | Withhold | FOR — 4 of 5 Equitable funds | Against | — |
| InnovAge Holding Corp. | 2025-12-04 | Election of Class II Directors: Teresa Sparks | Withhold | FOR — 4 of 5 Equitable funds | Against | — |
| Premier, Inc. | 2025-11-21 | A proposal to approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to the named executive officers of the Company in connection with the transactions contemplated by the merger agreement, including consummation of the merger (the "advisory compensation pro | Against | FOR — 4 of 5 Equitable funds | Against | Approved, 77.7% support |
| Sana Biotechnology, Inc. | 2026-06-04 | To elect three Class II directors to our Board of Directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders or until his or her respective successor is duly elected and qualified. The nominees for election are: Robert Nelsen | Withhold | FOR — 4 of 5 Equitable funds | Against | — |
| Select Medical Holdings Corporation | 2026-04-23 | Non-Binding Advisory Vote on a Company Proposal to provide stockholders the right to call a special meeting of stockholders at a 25% ownership threshold. | Against | FOR — 4 of 5 Equitable funds | Against | — |
| Select Medical Holdings Corporation | 2026-06-26 | To consider and vote on any proposal to adjourn the Special Meeting, from time to time, to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting (the "Adjournment Proposal"). | Abstain | FOR — 4 of 5 Equitable funds | Against | — |
| Select Medical Holdings Corporation | 2026-06-26 | To consider and vote on the proposal to adopt the Agreement and Plan of Merger (as it may be amended, supplemented or modified from time to time, the "Merger Agreement"), dated as of March 2, 2026, by and among Stallion Intermediate Corporation ("Parent"), Stallion MergerSub Corporation ("Merger Sub | Abstain | FOR — 4 of 5 Equitable funds | Against | — |
| Y-mAbs Therapeutics, Inc. | 2025-07-11 | Election of Class I Director: David N. Gill | Withhold | FOR — 4 of 5 Equitable funds | Against | Passed (calculated), 61.3% support |
| Alphabet Inc. | 2026-06-05 | Shareholder Shareholder proposal regarding a report on AI data usage oversight | For | AGAINST — 14 of 25 Equitable funds | Against | Not approved, 12.3% support |
| Alphabet Inc. | 2026-06-05 | Election of ten directors: L. John Doerr | Against | FOR — 14 of 25 Equitable funds | Against | Elected, 91.9% support |
| Meta Platforms, Inc. | 2026-05-27 | Election of Directors: Dana White | Withhold | FOR — 13 of 23 Equitable funds | Against | Elected, 91.4% support |
| Meta Platforms, Inc. | 2026-05-27 | Election of Directors: Tony Xu | Withhold | FOR — 13 of 23 Equitable funds | Against | Elected, 91.2% support |
| Advanced Micro Devices, Inc. | 2026-05-13 | Shareholder Stockholder proposal requesting changes to the stockholder right to call a special meeting. | For | AGAINST — 12 of 21 Equitable funds | Against | Not approved, 37.5% support |
| The Coca-Cola Company | 2026-04-29 | Shareholder Vote on a shareowner proposal requesting a report on the Company's plans to increase sustainability disclosure | For | AGAINST — 12 of 21 Equitable funds | Against | Failed (calculated), 22.3% support |
| QUALCOMM Incorporated | 2026-03-17 | Shareholder Stockholder proposal entitled "Shareholder Ability to Call for a Special Meeting." | For | AGAINST — 12 of 21 Equitable funds | Against | Not approved, 42.2% support |
| International Business Machines Corporation | 2026-04-28 | Shareholder Stockholder Proposal Requesting a Right to Act by Written Consent | For | AGAINST — 11 of 19 Equitable funds | Against | Failed (calculated), 37.3% support |
| CrowdStrike Holdings, Inc. | 2026-06-17 | To elect CrowdStrike's nominees Johanna Flower and Denis J. O'Leary to the Board of Directors to hold office until the 2029 Annual Meeting of Stockholders: Johanna Flower | Withhold | FOR — 9 of 15 Equitable funds | Against | Elected, 77.0% support |
| PepsiCo, Inc. | 2026-05-06 | Shareholder Shareholder Proposal - Report on Human Rights Oversight. | For | AGAINST — 11 of 19 Equitable funds | Against | Not approved, 16.5% support |
| Vertex Pharmaceuticals Incorporated | 2026-05-13 | Shareholder Shareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent. | For | AGAINST — 10 of 17 Equitable funds | Against | Approved, 57.0% support |
| AppLovin Corporation | 2026-06-03 | Election of Directors: BARBARA MESSING | Withhold | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 95.7% support |
| AppLovin Corporation | 2026-06-03 | Election of Directors: HERALD CHEN | Withhold | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 96.3% support |
| AppLovin Corporation | 2026-06-03 | Election of Directors: MARGARET GEORGIADIS | Withhold | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 92.1% support |
| AppLovin Corporation | 2026-06-03 | Election of Directors: MAYNARD WEBB | Withhold | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 95.7% support |
| AppLovin Corporation | 2026-06-03 | Election of Directors: TODD MORGENFELD | Withhold | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 99.2% support |
| Equinix, Inc. | 2026-05-13 | Election of directors to the Board of Directors (the "Board") to serve until the next Annual Meeting or until their successors have been duly elected and qualified: Sandra Rivera | Against | FOR — 11 of 19 Equitable funds | Against | Elected, 95.0% support |
| Adobe Inc. | 2026-04-15 | Approve, on an advisory basis, the compensation of our named executive officers. | Against | FOR — 10 of 17 Equitable funds | Against | Approved, 50.7% support |
| Adobe Inc. | 2026-04-15 | Election of the eleven (11) Directors proposed in the accompanying Proxy Statement to serve for a one-year term: Amy Banse | Against | FOR — 10 of 17 Equitable funds | Against | Passed (calculated), 85.5% support |
| United Parcel Service, Inc. | 2026-05-07 | To elect each of the 12 named director nominees to hold office until UPS's 2027 Annual Meeting of shareowners and until their respective successors are elected and qualified: Angela Hwang | Against | FOR — 9 of 15 Equitable funds | Against | Elected, 90.7% support |
| United Parcel Service, Inc. | 2026-05-07 | To elect each of the 12 named director nominees to hold office until UPS's 2027 Annual Meeting of shareowners and until their respective successors are elected and qualified: Carol Tome | Against | FOR — 9 of 15 Equitable funds | Against | Elected, 85.6% support |
| United Parcel Service, Inc. | 2026-05-07 | To elect each of the 12 named director nominees to hold office until UPS's 2027 Annual Meeting of shareowners and until their respective successors are elected and qualified: Christiana Smith Shi | Against | FOR — 9 of 15 Equitable funds | Against | Elected, 89.3% support |
| United Parcel Service, Inc. | 2026-05-07 | To elect each of the 12 named director nominees to hold office until UPS's 2027 Annual Meeting of shareowners and until their respective successors are elected and qualified: Eva Boratto | Against | FOR — 9 of 15 Equitable funds | Against | Elected, 90.3% support |
| United Parcel Service, Inc. | 2026-05-07 | To elect each of the 12 named director nominees to hold office until UPS's 2027 Annual Meeting of shareowners and until their respective successors are elected and qualified: Kevin Clark | Against | FOR — 9 of 15 Equitable funds | Against | Elected, 91.1% support |
| United Parcel Service, Inc. | 2026-05-07 | To elect each of the 12 named director nominees to hold office until UPS's 2027 Annual Meeting of shareowners and until their respective successors are elected and qualified: Rodney Adkins | Against | FOR — 9 of 15 Equitable funds | Against | Elected, 90.0% support |
| United Parcel Service, Inc. | 2026-05-07 | To elect each of the 12 named director nominees to hold office until UPS's 2027 Annual Meeting of shareowners and until their respective successors are elected and qualified: Wayne Hewett | Against | FOR — 9 of 15 Equitable funds | Against | Elected, 90.8% support |
| KKR & Co. Inc. | 2026-05-21 | An amendment to the Existing Charter to grant the Board the sole authority to fill board vacancies and newly created directorships. | Against | FOR — 10 of 17 Equitable funds | Against | — |
| Carvana Co. | 2026-05-05 | Election of Directors: Michael Maroone | Withhold | FOR — 9 of 15 Equitable funds | Against | Elected, 97.5% support |
| NIKE, Inc. | 2025-09-09 | Class B director nominees: To elect a Board of Directors for the ensuing year: John Rogers, Jr. | Withhold | FOR — 11 of 19 Equitable funds | Against | Passed (calculated), 64.7% support |
| Delta Air Lines, Inc. | 2026-06-18 | Shareholder A shareholder proposal requesting the ability for shareholders to act by written consent. | For | AGAINST — 9 of 15 Equitable funds | Against | Not approved, 31.5% support |
| Monolithic Power Systems, Inc. | 2026-06-11 | Election of Directors: Victor K. Lee | Withhold | FOR — 10 of 17 Equitable funds | Against | Passed (calculated), 89.8% support |
| eBay Inc. | 2026-06-17 | Shareholder Special stockholder meeting threshold, if properly presented. | For | AGAINST — 10 of 17 Equitable funds | Against | Not approved, 42.8% support |
| Ford Motor Company | 2026-05-14 | Election of Directors: Adriana Cisneros | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 98.2% support |
| Ford Motor Company | 2026-05-14 | Election of Directors: Alexandra Ford English | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 97.7% support |
| Ford Motor Company | 2026-05-14 | Election of Directors: Beth E. Mooney | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 98.2% support |
| Ford Motor Company | 2026-05-14 | Election of Directors: Henry Ford III | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 97.7% support |
| Ford Motor Company | 2026-05-14 | Election of Directors: James D. Farley, Jr. | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 97.6% support |
| Ford Motor Company | 2026-05-14 | Election of Directors: John B. Veihmeyer | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 97.8% support |
| Ford Motor Company | 2026-05-14 | Election of Directors: John C. May | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 98.2% support |
| Ford Motor Company | 2026-05-14 | Election of Directors: John L. Thornton | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 96.4% support |
| Ford Motor Company | 2026-05-14 | Election of Directors: John S. Weinberg | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 98.1% support |
| Ford Motor Company | 2026-05-14 | Election of Directors: Jon M. Huntsman, Jr. | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 92.4% support |
| Ford Motor Company | 2026-05-14 | Election of Directors: Kimberly A. Casiano | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 96.6% support |
| Ford Motor Company | 2026-05-14 | Election of Directors: Lynn Radakovich | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 97.5% support |
| Ford Motor Company | 2026-05-14 | Election of Directors: William Clay Ford, Jr. | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 91.1% support |
| Ford Motor Company | 2026-05-14 | Election of Directors: William E. Kennard | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 81.8% support |
| Ford Motor Company | 2026-05-14 | Election of Directors: William W. Helman IV | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 97.0% support |
| Devon Energy Corporation | 2026-05-04 | Approve an amendment of Devon Energy Corporation's restated certificate of incorporation to increase the number of authorized shares of common stock from 1,000,000,000 to 2,000,000,000 (the "Authorized Share Charter Amendment Proposal", together with Stock Issuance Proposal, the "Devon Merger Propos | Abstain | FOR — 10 of 17 Equitable funds | Against | — |
| Devon Energy Corporation | 2026-05-04 | Approve the adjournment of the Devon Energy Corporation special meeting of stockholders (the "Devon Special Meeting of Stockholders"), if necessary or appropriate, for the purpose of soliciting additional votes for the approval of the Devon Merger Proposals. | Abstain | FOR — 10 of 17 Equitable funds | Against | — |
| Devon Energy Corporation | 2026-05-04 | Approve the issuance of shares of Devon Energy Corporation common stock to the holders of Coterra Energy Inc. common stock in connection with the merger, as contemplated by the Merger Agreement (the "Stock Issuance Proposal"). | Abstain | FOR — 10 of 17 Equitable funds | Against | — |
| Ares Management Corporation | 2026-06-08 | Election of Directors: Antoinette Bush | Against | FOR — 10 of 17 Equitable funds | Against | Elected, 94.3% support |
| Live Nation Entertainment, Inc. | 2026-06-11 | To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Maverick Carter | Against | FOR — 10 of 17 Equitable funds | Against | Elected, 89.2% support |
| Prudential Financial, Inc. | 2026-05-12 | Shareholder Shareholder proposal regarding an Independent Board Chairman. | For | AGAINST — 9 of 15 Equitable funds | Against | Not approved, 30.5% support |
| Cboe Global Markets, Inc. | 2026-05-14 | Shareholder Stockholder proposal regarding shareholder right to act by written consent. | For | AGAINST — 10 of 17 Equitable funds | Against | — |
| Royalty Pharma plc | 2026-06-04 | Election of Directors: Vlad Coric, M.D. | Against | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 88.8% support |
| Vulcan Materials Company | 2026-05-08 | Election of Directors: George A. Willis | Against | FOR — 9 of 15 Equitable funds | Against | Elected, 98.5% support |
| Vulcan Materials Company | 2026-05-08 | Election of Directors: James T. Prokopanko | Against | FOR — 9 of 15 Equitable funds | Against | Elected, 92.8% support |
| Vulcan Materials Company | 2026-05-08 | Election of Directors: Melissa H. Anderson | Against | FOR — 9 of 15 Equitable funds | Against | Elected, 99.2% support |
| Vulcan Materials Company | 2026-05-08 | Election of Directors: O.B. Grayson Hall, Jr. | Against | FOR — 9 of 15 Equitable funds | Against | Elected, 96.6% support |
| Arch Capital Group Ltd. | 2026-05-05 | To elect the nominees listed as Class I Directors of the Company for a term of three years and until their respective successors are duly elected and qualified or their earlier resignation or removal: Brian S. Posner | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 96.6% support |
| Arch Capital Group Ltd. | 2026-05-05 | To elect the nominees listed as Class I Directors of the Company for a term of three years and until their respective successors are duly elected and qualified or their earlier resignation or removal: Eileen Mallesch | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 97.8% support |
| Arch Capital Group Ltd. | 2026-05-05 | To elect the nominees listed as Class I Directors of the Company for a term of three years and until their respective successors are duly elected and qualified or their earlier resignation or removal: Francis Ebong | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 88.7% support |
| United Airlines Holdings, Inc. | 2026-05-19 | Shareholder Advisory vote on stockholder proposal entitled "Shareholder Right to Act by Written Consent". | For | AGAINST — 9 of 15 Equitable funds | Against | Not approved, 39.6% support |
| Archer-Daniels-Midland Company | 2026-05-07 | Election of Directors: D.A. Sandler | Against | FOR — 10 of 17 Equitable funds | Against | Elected, 96.8% support |
| Archer-Daniels-Midland Company | 2026-05-07 | Election of Directors: D.R. McAtee II | Against | FOR — 10 of 17 Equitable funds | Against | Elected, 99.0% support |
| Archer-Daniels-Midland Company | 2026-05-07 | Election of Directors: E. de Brabander | Against | FOR — 10 of 17 Equitable funds | Against | Elected, 98.7% support |
| Archer-Daniels-Midland Company | 2026-05-07 | Election of Directors: J.C. Collins, Jr. | Against | FOR — 10 of 17 Equitable funds | Against | Elected, 99.0% support |
| Archer-Daniels-Midland Company | 2026-05-07 | Election of Directors: K.R. Westbrook | Against | FOR — 10 of 17 Equitable funds | Against | Elected, 96.1% support |
| Archer-Daniels-Midland Company | 2026-05-07 | Election of Directors: L.Z. Schlitz | Against | FOR — 10 of 17 Equitable funds | Against | Elected, 99.0% support |
| Archer-Daniels-Midland Company | 2026-05-07 | Election of Directors: M.S. Burke | Against | FOR — 10 of 17 Equitable funds | Against | Elected, 97.8% support |
| Archer-Daniels-Midland Company | 2026-05-07 | Election of Directors: P.J. Moore | Against | FOR — 10 of 17 Equitable funds | Against | Elected, 95.8% support |
| Archer-Daniels-Midland Company | 2026-05-07 | Election of Directors: S.F. Harrison | Against | FOR — 10 of 17 Equitable funds | Against | Elected, 98.5% support |
| Archer-Daniels-Midland Company | 2026-05-07 | Election of Directors: T. Colbert | Against | FOR — 10 of 17 Equitable funds | Against | Elected, 99.0% support |
| Archer-Daniels-Midland Company | 2026-05-07 | Election of Directors: T.K. Crews | Against | FOR — 10 of 17 Equitable funds | Against | Elected, 98.0% support |
| Extra Space Storage Inc. | 2026-05-14 | Advisory vote on the compensation of the Company's named executive officers. | Against | FOR — 10 of 17 Equitable funds | Against | Passed (calculated), 93.2% support |
| W. R. Berkley Corporation | 2026-06-03 | Election of Directors: Daniel L. Mosley | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 97.9% support |
| W. R. Berkley Corporation | 2026-06-03 | Election of Directors: Maria Luisa Ferre | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 94.2% support |
| W. R. Berkley Corporation | 2026-06-03 | Election of Directors: Robert A. Rusbuldt | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 98.2% support |
| W. R. Berkley Corporation | 2026-06-03 | Election of Directors: W. Robert Berkley, Jr. | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 99.1% support |
| West Pharmaceutical Services, Inc. | 2026-05-04 | Shareholder Shareholder proposal regarding an independent Board Chair policy. | For | AGAINST — 10 of 17 Equitable funds | Against | Not approved, 46.4% support |
| Church & Dwight Co., Inc. | 2026-05-01 | Shareholder Stockholder Proposal - Permit Stockholder Action by Written Consent. | For | AGAINST — 10 of 17 Equitable funds | Against | — |
| Regions Financial Corporation | 2026-05-06 | Shareholder Shareholder Proposal Relating to Special Shareholder Meeting. | For | AGAINST — 9 of 15 Equitable funds | Against | Not approved, 43.9% support |
| Principal Financial Group, Inc. | 2026-05-19 | Election of Directors: Claudio N. Muruzabal | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 98.1% support |
| Principal Financial Group, Inc. | 2026-05-19 | Election of Directors: Jocelyn Carter-Miller | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 88.4% support |
| Principal Financial Group, Inc. | 2026-05-19 | Election of Directors: Jonathan S. Auerbach | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 99.1% support |
| Principal Financial Group, Inc. | 2026-05-19 | Election of Directors: Mary E. "Maliz" Beams | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 99.0% support |
| Principal Financial Group, Inc. | 2026-05-19 | Election of Directors: Scott M. Mills | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 97.7% support |
| Tyson Foods, Inc. | 2026-02-05 | Election of Directors: Cheryl S. Miller | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 91.6% support |
| Tyson Foods, Inc. | 2026-02-05 | Election of Directors: Donnie King | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 99.0% support |
| Tyson Foods, Inc. | 2026-02-05 | Election of Directors: Jeffrey K. Schomburger | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 97.7% support |
| Tyson Foods, Inc. | 2026-02-05 | Election of Directors: John H. Tyson | Against | FOR — 9 of 15 Equitable funds | Against | — |
| Tyson Foods, Inc. | 2026-02-05 | Election of Directors: Kate B. Quinn | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 99.0% support |
| Tyson Foods, Inc. | 2026-02-05 | Election of Directors: Maria Claudia Borras | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 94.3% support |
| Tyson Foods, Inc. | 2026-02-05 | Election of Directors: Maria N. Martinez | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 94.4% support |
| Tyson Foods, Inc. | 2026-02-05 | Election of Directors: Mike Beebe | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 94.2% support |
| Tyson Foods, Inc. | 2026-02-05 | To approve the amendment and restatement of the Tyson Foods, Inc. 2000 Stock Incentive Plan, a copy of which is attached to the Proxy Statement as Exhibit A. | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 91.8% support |
| General Mills, Inc. | 2025-09-30 | Shareholder Shareholder Proposal - Disclosure of Regenerative Agriculture Practices Within Supply Chain. | For | AGAINST — 10 of 17 Equitable funds | Against | Failed (calculated), 28.1% support |
| Texas Pacific Land Corporation | 2025-11-06 | To elect the nine directors named in the Proxy Statement to serve until the 2026 Annual Meeting of Stockholders: Murray Stahl | Against | FOR — 10 of 17 Equitable funds | Against | Passed (calculated), 95.8% support |
| News Corporation | 2025-11-19 | Election of 6 Directors: Robert J. Thomson | Against | FOR — 9 of 15 Equitable funds | Against | Elected, 99.2% support |
| Skyworks Solutions, Inc. | 2026-05-13 | Shareholder To approve a stockholder proposal regarding greenhouse gas emission reduction efforts report. | For | AGAINST — 10 of 17 Equitable funds | Against | Not approved, 16.6% support |
| Universal Health Services, Inc. | 2026-05-20 | Shareholder Stockholder proposal to adopt a policy requiring Universal Health Services, Inc. to publicly disclose its workforce diversity, if properly presented at the meeting. | For | AGAINST — 9 of 15 Equitable funds | Against | — |
| Align Technology, Inc. | 2026-05-20 | ELECTION OF DIRECTORS: Joseph Lacob | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 95.6% support |
| Akamai Technologies, Inc. | 2026-05-13 | Shareholder To vote upon a shareholder proposal requiring the Company to provide a report on political spending. | For | AGAINST — 10 of 17 Equitable funds | Against | Not approved, 45.7% support |
| Insulet Corporation | 2026-05-20 | Election of Directors: Luciana Borio | Withhold | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 93.5% support |
| Insulet Corporation | 2026-05-20 | Election of Directors: Michael R. Minogue | Withhold | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 91.1% support |
| Insulet Corporation | 2026-05-20 | Election of Directors: Timothy C. Stonesifer | Withhold | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 95.4% support |
| Wynn Resorts, Limited | 2026-05-06 | To elect three Class III directors to serve until the 2029 Annual Meeting of Shareholders: Patricia Mulroy | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 95.0% support |
| Wynn Resorts, Limited | 2026-05-06 | To elect three Class III directors to serve until the 2029 Annual Meeting of Shareholders: Philip G. Satre | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 99.0% support |
| Wynn Resorts, Limited | 2026-05-06 | To elect three Class III directors to serve until the 2029 Annual Meeting of Shareholders: Richard J. Byrne | Against | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 93.9% support |
| PACS Group, Inc. | 2025-12-19 | To elect Taylor Leavitt and Jacqueline Millard as Class I directors to serve until the 2028 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified: Jacqueline Millard | Withhold | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 97.0% support |
| PACS Group, Inc. | 2025-12-19 | To elect Taylor Leavitt and Jacqueline Millard as Class I directors to serve until the 2028 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified: Taylor Leavitt | Withhold | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 97.0% support |
| 10x Genomics, Inc. | 2026-06-04 | Election of the Class I directors listed in the accompanying proxy statement, to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualificatio | Against | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 91.3% support |
| 10x Genomics, Inc. | 2026-06-04 | Election of the Class I directors listed in the accompanying proxy statement, to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualificatio | Against | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 90.7% support |
| Compass, Inc. | 2026-05-14 | Election of Class II Directors: Allan Leinwand | Against | FOR — 5 of 7 Equitable funds | Against | Elected, 97.0% support |
| Compass, Inc. | 2026-05-14 | Election of Class II Directors: Charles Phillips | Against | FOR — 5 of 7 Equitable funds | Against | Elected, 86.3% support |
| Compass, Inc. | 2026-05-14 | Election of Class II Directors: Pamela Thomas-Graham | Against | FOR — 5 of 7 Equitable funds | Against | Elected, 96.7% support |
| Ormat Technologies, Inc. | 2026-06-02 | To elect the eight director nominees listed below to the Board of Directors to hold office until the 2027 Annual Meeting of Stockholders: Michal Marom | Against | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 94.7% support |
| New Jersey Resources Corporation | 2026-01-21 | Election of the following five Directors that were named in the Proxy Statement; each for a term expiring in 2029: Jane M. Kenny | Withhold | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 95.0% support |
| New Jersey Resources Corporation | 2026-01-21 | Election of the following five Directors that were named in the Proxy Statement; each for a term expiring in 2029: Sharon C. Taylor | Withhold | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 97.1% support |
| Scholar Rock Holding Corporation | 2026-06-04 | To elect four Class II directors to our Board of Directors, each to serve until the 2029 Annual Meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal: Katie Peng | Withhold | FOR — 5 of 7 Equitable funds | Against | Elected, 86.8% support |
| PTC Therapeutics, Inc. | 2026-06-02 | Election of Four Class I Directors: Jerome B. Zeldis, M.D., Ph.D. | Withhold | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 96.1% support |
| PTC Therapeutics, Inc. | 2026-06-02 | Election of Four Class I Directors: Stephanie S. Okey, M.S. | Withhold | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 94.8% support |
| Red Rock Resorts, Inc. | 2026-06-04 | Election of 5 director nominees: Frank J. Fertitta III | Withhold | FOR — 5 of 7 Equitable funds | Against | Elected, 98.8% support |
| Red Rock Resorts, Inc. | 2026-06-04 | Election of 5 director nominees: Lorenzo J. Fertitta | Withhold | FOR — 5 of 7 Equitable funds | Against | Elected, 98.2% support |
| UFP Industries, Inc. | 2026-04-22 | 2 wordings Election of Directors To elect one director to serve until 2028: Mary Tuuk Kuras | Against | FOR — 5 of 7 Equitable funds | Against | Elected, 91.6% support |
| Flagstar Bank, N.A. | 2026-06-09 | An advisory vote to approve, on a non-binding basis, compensation of our named executive officers disclosed in the accompanying proxy statement. | Against | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 81.2% support |
| AAR Corp. | 2025-09-16 | Election of four directors named in the proxy statement: Ellen M. Lord | Against | FOR — 5 of 7 Equitable funds | Against | Elected, 93.7% support |
| AAR Corp. | 2025-09-16 | Election of four directors named in the proxy statement: Jeffrey N. Edwards | Against | FOR — 5 of 7 Equitable funds | Against | Elected, 82.1% support |
| AAR Corp. | 2025-09-16 | Election of four directors named in the proxy statement: Marc J. Walfish | Against | FOR — 5 of 7 Equitable funds | Against | Elected, 90.9% support |
| Lumen Technologies, Inc. | 2026-05-20 | Shareholder Approval of a shareholder proposal regarding a shareholder right to vote for or against a poison pill. | For | AGAINST — 5 of 7 Equitable funds | Against | Not approved, 47.8% support |
| Wesbanco, Inc. | 2026-04-15 | To approve an advisory (non-binding) vote on compensation paid to Wesbanco's named executive officers in 2025. | Against | FOR — 5 of 7 Equitable funds | Against | Approved, 64.6% support |
| Oklo Inc. | 2026-06-03 | Election of Directors: Richard W. Kinzley | Withhold | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 83.3% support |
| Dyne Therapeutics, Inc. | 2026-06-05 | To elect three Class III directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified: David Lubner | Withhold | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 91.5% support |
| Dyne Therapeutics, Inc. | 2026-06-05 | To elect three Class III directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified: Jason Rhodes | Withhold | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 87.4% support |
| Bank of Hawaii Corporation | 2026-04-24 | Say on Pay - An advisory vote on executive compensation. | Against | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 59.8% support |
| Stoke Therapeutics, Inc. | 2026-06-03 | Election of Class I Directors to serve until the 2029 annual meeting of stockholders or until their successor has been duly elected and qualified or until their earlier resignation or removal: Julie Anne Smith | Withhold | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 86.9% support |
| Stoke Therapeutics, Inc. | 2026-06-03 | To approve, on an advisory basis, the compensation of the Company's named executive officers. | Against | FOR — 5 of 7 Equitable funds | Against | Passed (calculated), 72.9% support |
| Yext, Inc. | 2026-06-10 | Approve the amended, restated and extended Yext, Inc. 2016 Equity Incentive Plan. | Against | FOR — 5 of 7 Equitable funds | Against | — |
| Aeva Technologies, Inc. | 2026-06-18 | Election of Class II Directors: Stephen Zadesky | Withhold | FOR — 5 of 7 Equitable funds | Against | — |
| Coterra Energy Inc. | 2026-05-04 | To approve the adjournment of the Coterra Special Meeting, if necessary or appropriate, for the purpose of soliciting additional votes for the approval of the Coterra Merger Proposal (the "Coterra Adjournment Proposal"). | Abstain | FOR — 10 of 17 Equitable funds | Against | — |
| Electronic Arts Inc. | 2025-08-14 | Advisory vote to approve named executive officer compensation. | Against | FOR — 10 of 17 Equitable funds | Against | Passed (calculated), 90.4% support |
| Warner Bros. Discovery, Inc. | 2026-06-09 | ELECTION OF DIRECTORS: Anton J. Levy | Withhold | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 96.6% support |
| Warner Bros. Discovery, Inc. | 2026-06-09 | ELECTION OF DIRECTORS: Daniel E. Sanchez | Withhold | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 99.0% support |
| Warner Bros. Discovery, Inc. | 2026-06-09 | ELECTION OF DIRECTORS: David M. Zaslav | Withhold | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 96.6% support |
| Warner Bros. Discovery, Inc. | 2026-06-09 | ELECTION OF DIRECTORS: Debra L. Lee | Withhold | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 68.2% support |
| Warner Bros. Discovery, Inc. | 2026-06-09 | ELECTION OF DIRECTORS: Fazal F. Merchant | Withhold | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 96.6% support |
| Warner Bros. Discovery, Inc. | 2026-06-09 | ELECTION OF DIRECTORS: Geoffrey Y. Yang | Withhold | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 68.9% support |
| Warner Bros. Discovery, Inc. | 2026-06-09 | ELECTION OF DIRECTORS: Joseph M. Levin | Withhold | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 77.8% support |
| Warner Bros. Discovery, Inc. | 2026-06-09 | ELECTION OF DIRECTORS: Kenneth W. Lowe | Withhold | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 68.8% support |
| Warner Bros. Discovery, Inc. | 2026-06-09 | ELECTION OF DIRECTORS: Paula A. Price | Withhold | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 98.7% support |
| Warner Bros. Discovery, Inc. | 2026-06-09 | ELECTION OF DIRECTORS: Richard W. Fisher | Withhold | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 68.6% support |
| Warner Bros. Discovery, Inc. | 2026-06-09 | ELECTION OF DIRECTORS: Samuel A. Di Piazza, Jr. | Withhold | FOR — 9 of 15 Equitable funds | Against | Passed (calculated), 98.2% support |
| Meta Platforms, Inc. | 2026-05-27 | Election of Directors: Andrew W. Houston | Withhold | FOR — 13 of 24 Equitable funds | Against | Elected, 91.1% support |
| Marvell Technology, Inc. | 2026-06-25 | An advisory (non-binding) vote to approve compensation of our named executive officers. | Against | FOR — 7 of 11 Equitable funds | Against | Approved, 55.9% support |
| Marsh & McLennan Companies, Inc. | 2026-05-21 | Advisory (Nonbinding) Vote to Approve Named Executive Officer Compensation | Against | FOR — 12 of 22 Equitable funds | Against | Approved, 88.5% support |
| Chart Industries, Inc. | 2025-10-06 | To approve, by a non-binding advisory vote, certain compensation that may be paid or become payable to Chart's named executive officers that is based on or otherwise relates to the Merger. | Against | FOR — 6 of 9 Equitable funds | Against | Approved, 95.2% support |
| International Bancshares Corporation | 2026-05-18 | ELECTION OF DIRECTORS: A. R. Sanchez, Jr. | For | AGAINST — 6 of 9 Equitable funds | For | Elected, 85.9% support |
| Eli Lilly and Company | 2026-05-04 | Shareholder Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. | For | AGAINST — 10 of 18 Equitable funds | Against | Not approved, 33.7% support |
| Caterpillar, Inc. | 2026-06-10 | Shareholder Shareholder Proposal - Shareholder Right to Act by Written Consent | For | AGAINST — 11 of 20 Equitable funds | Against | Not approved, 39.5% support |
| Lam Research Corporation | 2025-11-04 | Shareholder Stockholder proposal titled "Realistic Shareholder Ability to Call for a Special Shareholder Meeting," if properly presented. | For | AGAINST — 11 of 20 Equitable funds | Against | — |
| Arista Networks, Inc. | 2026-05-29 | Election of Directors: Greg Lavender | Withhold | FOR — 10 of 18 Equitable funds | Against | Elected, 79.1% support |
| Arista Networks, Inc. | 2026-05-29 | Election of Directors: Lewis Chew | Withhold | FOR — 10 of 18 Equitable funds | Against | Elected, 78.3% support |
| McDonald's Corporation | 2026-05-20 | Shareholder Advisory Vote on Shareholders' Right to Act by Written Consent. | For | AGAINST — 11 of 20 Equitable funds | Against | Failed (calculated), 41.9% support |
| Analog Devices, Inc. | 2026-03-11 | Shareholder To consider a shareholder proposal, if properly presented at the Annual Meeting. | For | AGAINST — 10 of 18 Equitable funds | Against | — |
| Simon Property Group, Inc. | 2026-05-13 | Election of Directors: Daniel C. Smith, Ph.D. | Against | FOR — 11 of 20 Equitable funds | Against | Elected, 95.4% support |
| Simon Property Group, Inc. | 2026-05-13 | Election of Directors: Gary M. Rodkin | Against | FOR — 11 of 20 Equitable funds | Against | Elected, 96.3% support |
| Simon Property Group, Inc. | 2026-05-13 | Election of Directors: Glyn F. Aeppel | Against | FOR — 11 of 20 Equitable funds | Against | Elected, 87.8% support |
| Simon Property Group, Inc. | 2026-05-13 | Election of Directors: Larry C. Glasscock | Against | FOR — 11 of 20 Equitable funds | Against | Elected, 92.3% support |
| Simon Property Group, Inc. | 2026-05-13 | Election of Directors: Marta R. Stewart | Against | FOR — 11 of 20 Equitable funds | Against | Elected, 98.7% support |
| Simon Property Group, Inc. | 2026-05-13 | Election of Directors: Nina P. Jones | Against | FOR — 11 of 20 Equitable funds | Against | Elected, 99.2% support |
| Simon Property Group, Inc. | 2026-05-13 | Election of Directors: Peggy Fang Roe | Against | FOR — 11 of 20 Equitable funds | Against | Elected, 96.6% support |
| Simon Property Group, Inc. | 2026-05-13 | Election of Directors: Randall J. Lewis | Against | FOR — 11 of 20 Equitable funds | Against | Elected, 99.2% support |
| Simon Property Group, Inc. | 2026-05-13 | Election of Directors: Reuben S. Leibowitz | Against | FOR — 11 of 20 Equitable funds | Against | Elected, 91.0% support |
| Simon Property Group, Inc. | 2026-05-13 | Election of Directors: Stefan M. Selig | Against | FOR — 11 of 20 Equitable funds | Against | Elected, 98.4% support |
| Block, Inc. | 2026-06-16 | TO ELECT FOUR CLASS II DIRECTORS TO SERVE UNTIL OUR 2029 ANNUAL MEETING OF STOCKHOLDERS AND UNTIL THEIR SUCCESSORS ARE DULY ELECTED AND QUALIFIED: JAMES MCKELVEY | Withhold | FOR — 10 of 18 Equitable funds | Against | Elected, 93.8% support |
| Block, Inc. | 2026-06-16 | TO ELECT FOUR CLASS II DIRECTORS TO SERVE UNTIL OUR 2029 ANNUAL MEETING OF STOCKHOLDERS AND UNTIL THEIR SUCCESSORS ARE DULY ELECTED AND QUALIFIED: SHAWN CARTER | Withhold | FOR — 10 of 18 Equitable funds | Against | Elected, 92.4% support |
| Rockwell Automation, Inc. | 2026-02-10 | To elect as directors of Rockwell Automation, Inc. the nominees listed below: Pam Murphy | Withhold | FOR — 11 of 20 Equitable funds | Against | Elected, 91.6% support |
| Rockwell Automation, Inc. | 2026-02-10 | To elect as directors of Rockwell Automation, Inc. the nominees listed below: Robert W. Soderbery | Withhold | FOR — 11 of 20 Equitable funds | Against | Elected, 95.4% support |
| GE Healthcare Technologies, Inc. | 2026-05-07 | Election of Directors: Kevin A. Lobo | Against | FOR — 10 of 18 Equitable funds | Against | Passed (calculated), 91.2% support |
| The Hershey Company | 2026-05-05 | Election of Directors: Barry J. Nalebuff | Against | FOR — 10 of 18 Equitable funds | Against | Passed (calculated), 99.8% support |
| The Hershey Company | 2026-05-05 | Election of Directors: Cordel Robbin-Coker | Against | FOR — 10 of 18 Equitable funds | Against | Passed (calculated), 99.6% support |
| The Hershey Company | 2026-05-05 | Election of Directors: Kevin M. Ozan | Against | FOR — 10 of 18 Equitable funds | Against | Passed (calculated), 99.8% support |
| The Hershey Company | 2026-05-05 | Election of Directors: Marie Quintero-Johnson | Against | FOR — 10 of 18 Equitable funds | Against | Passed (calculated), 99.8% support |
| First Solar, Inc. | 2026-05-13 | Shareholder Stockholder proposal to improve shareholder ability to call for a special shareholder meeting | For | AGAINST — 10 of 18 Equitable funds | Against | Not approved, 43.2% support |
| Fidelity National Information Services, Inc. | 2026-06-10 | To approve, on an advisory basis, the compensation of the Company's named executive officers. | Against | FOR — 10 of 18 Equitable funds | Against | Approved, 70.6% support |
| Paycom Software, Inc. | 2026-05-04 | To elect two Class I directors, each to serve until the date of the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or his or her earlier death, resignation or removal: J.C. Watts, Jr. | Against | FOR — 10 of 18 Equitable funds | Against | Passed (calculated), 74.2% support |
| Paycom Software, Inc. | 2026-05-04 | To elect two Class I directors, each to serve until the date of the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or his or her earlier death, resignation or removal: Sharen J. Turney | Against | FOR — 10 of 18 Equitable funds | Against | Passed (calculated), 63.5% support |
| Domino's Pizza, Inc. | 2026-04-21 | Shareholder Shareholder proposal regarding an independent board chair requirement. | For | AGAINST — 11 of 20 Equitable funds | Against | Not approved, 39.9% support |
| Henry Schein, Inc. | 2026-05-21 | Election of Incumbent Directors: Max Lin | For | AGAINST — 10 of 18 Equitable funds | For | Passed (calculated), 77.3% support |
| Hologic, Inc. | 2026-02-05 | A proposal to approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to the named executive officers of the Company in connection with the transactions contemplated by the merger agreement, including consummation of the merger. | For | AGAINST — 10 of 18 Equitable funds | For | — |
| Alphabet Inc. | 2026-06-05 | Election of ten directors: John L. Hennessy | Against | FOR — 13 of 25 Equitable funds | Against | Elected, 85.2% support |
| Berkshire Hathaway Inc. | 2026-05-02 | Election of Directors: Ajit Jain | Withhold | FOR — 9 of 16 Equitable funds | Against | Passed (calculated), 98.9% support |
| Berkshire Hathaway Inc. | 2026-05-02 | Election of Directors: Christopher C. Davis | Withhold | FOR — 9 of 16 Equitable funds | Against | Passed (calculated), 97.9% support |
| Berkshire Hathaway Inc. | 2026-05-02 | Election of Directors: Gregory E. Abel | Withhold | FOR — 9 of 16 Equitable funds | Against | Passed (calculated), 99.2% support |
| Berkshire Hathaway Inc. | 2026-05-02 | Election of Directors: Howard G. Buffett | Withhold | FOR — 9 of 16 Equitable funds | Against | Passed (calculated), 98.3% support |
| Berkshire Hathaway Inc. | 2026-05-02 | Election of Directors: Meryl B. Witmer | Withhold | FOR — 9 of 16 Equitable funds | Against | Passed (calculated), 98.2% support |
| Berkshire Hathaway Inc. | 2026-05-02 | Election of Directors: Susan A. Buffett | Withhold | FOR — 9 of 16 Equitable funds | Against | Passed (calculated), 98.1% support |
| Berkshire Hathaway Inc. | 2026-05-02 | Election of Directors: Wallace R. Weitz | Withhold | FOR — 9 of 16 Equitable funds | Against | Passed (calculated), 98.7% support |
| Berkshire Hathaway Inc. | 2026-05-02 | Election of Directors: Warren E. Buffett | Withhold | FOR — 9 of 16 Equitable funds | Against | Passed (calculated), 97.6% support |
| Palantir Technologies Inc. | 2026-06-03 | Election of Directors: Alexander Karp | Withhold | FOR — 9 of 16 Equitable funds | Against | Elected, 93.1% support |
| Palantir Technologies Inc. | 2026-06-03 | Election of Directors: Alexander Moore | Withhold | FOR — 9 of 16 Equitable funds | Against | Elected, 85.5% support |
| Palantir Technologies Inc. | 2026-06-03 | Election of Directors: Alexandra Schiff | Withhold | FOR — 9 of 16 Equitable funds | Against | Elected, 86.1% support |
| Palantir Technologies Inc. | 2026-06-03 | Election of Directors: Eric Woersching | Withhold | FOR — 9 of 16 Equitable funds | Against | Elected, 99.3% support |
| Palantir Technologies Inc. | 2026-06-03 | Election of Directors: Lauren Friedman Stat | Withhold | FOR — 9 of 16 Equitable funds | Against | Elected, 99.2% support |
| Palantir Technologies Inc. | 2026-06-03 | Election of Directors: Stephen Cohen | Withhold | FOR — 9 of 16 Equitable funds | Against | Elected, 93.0% support |
| T-Mobile US, Inc. | 2026-06-16 | Election of Directors: Thorsten Langheim | Withhold | FOR — 9 of 16 Equitable funds | Against | Passed (calculated), 89.8% support |
627 more in the CSV.
Download all 1,127 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 97.3% of this fund’s 15,797 such votes could be given a sector; the other 433 (2.7%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Consumer Discretionary | 3,125 | 120 | 3.8% |
| Finance | 2,913 | 46 | 1.6% |
| Industrials | 2,226 | 58 | 2.6% |
| Health Care | 1,994 | 44 | 2.2% |
| Technology | 1,932 | 86 | 4.5% |
| Real Estate | 1,025 | 4 | 0.4% |
| Utilities | 718 | 18 | 2.5% |
| Energy | 571 | 7 | 1.2% |
| Consumer Staples | 412 | 22 | 5.3% |
| Telecommunications | 224 | 10 | 4.5% |
| Basic Materials | 121 | 1 | 0.8% |
| Miscellaneous | 103 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 11,298 | 11 |
| Say-on-Pay | 1,540 | 0 |
| Audit-related | 1,477 | 0 |
| Corporate Governance | 570 | 208 |
| Compensation | 500 | 11 |
| Capital Structure | 170 | 0 |
| Extraordinary Transactions | 116 | 1 |
| Environment or Climate | 76 | 76 |
| Other Social Issues | 65 | 62 |
| Shareholder Rights and Defenses | 57 | 21 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Apple Inc. | February 24, 2026 | $616M | 12 | 1 |
| Microsoft Corporation | December 5, 2025 | $474M | 21 | 5 |
| NVIDIA Corporation | June 24, 2026 | $429M | 16 | 4 |
| Meta Platforms, Inc. | May 27, 2026 | $321M | 22 | 9 |
| Amazon.com, Inc. | May 20, 2026 | $292M | 17 | 4 |
| Alphabet Inc. | June 5, 2026 | $193M | 23 | 10 |
| Broadcom Inc. | April 20, 2026 | $183M | 10 | 0 |
| Eli Lilly and Company | May 4, 2026 | $136M | 10 | 2 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| February 24, 2026 | Apple Inc. | A shareholder proposal entitled "China Entanglement Audit" Shareholder proposal | Against | For |
| December 5, 2025 | Microsoft Corporation | European Security Program Censorship Risk Audit Shareholder proposal | Against | For |
| December 5, 2025 | Microsoft Corporation | Report on Risks of Censorship in Generative Artificial Intelligence Shareholder proposal | Against | For |
| June 24, 2026 | NVIDIA Corporation | Approval of a non-binding stockholder proposal requesting the replacement of supermajority voting provisions in our charter and bylaws with a simple majority voting standard. Shareholder proposal | For | Against |
| June 24, 2026 | NVIDIA Corporation | Approval of a non-binding stockholder proposal requesting a report on faith-based community resource groups. Shareholder proposal | Against | For |
| May 27, 2026 | Meta Platforms, Inc. | A shareholder proposal regarding report on Al data usage oversight. Shareholder proposal | Against | For |
| May 27, 2026 | Meta Platforms, Inc. | A shareholder proposal regarding annual vote regarding executive pay. Shareholder proposal | For | Against |
| May 20, 2026 | Amazon.com, Inc. | SHAREHOLDER PROPOSAL REQUESTING A REPORT ON CHARITABLE PARTNERSHIPS Shareholder proposal | Against | For |
| May 20, 2026 | Amazon.com, Inc. | SHAREHOLDER PROPOSAL REQUESTING ADDITIONAL REPORTING ON IMPACT OF DATA CENTERS ON CLIMATE COMMITMENTS Shareholder proposal | Against | For |
| June 5, 2026 | Alphabet Inc. | Shareholder proposal regarding an enhanced disclosure on climate goals Shareholder proposal | For | Against |
| June 5, 2026 | Alphabet Inc. | Shareholder proposal regarding a report on water usage and AI development Shareholder proposal | Against | For |
| May 4, 2026 | Eli Lilly and Company | Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposal | For | Against |
Meetings with a proxy contest or competing nominees (5 in 2025-2026), and how the fund voted the items on its ballot.
15,898 ballot items at 1,550 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, EQ/Common Stock Index Portfolio voted at 1,550 shareholder meetings of 1,485 companies, on 15,898 ballot items in all. Where management made a recommendation, the fund followed it on 97.0% of the items and voted against it 417 times. Its most frequent area of disagreement was corporate governance (208 of its votes against management). It voted FOR 39.8% of the 417 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals less often than Equitable's funds as a whole (87.8% against 92.5%). It voted differently from most Equitable funds on 1,127 items. 5 of its meetings were contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Equitable’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.